Tags
- 11beta-HSD1
- 1D00C3
- 23andMe
- 3-V Biosciences
- 3M
- 3SBio
- 4-Antibody
- 454 Life Sciences
- 4SC AG
- 5AM
- 5AM Solutions
- 6R-BH4
- 7TM Pharma
- 893
- A.P. Pharma
- A0001
- AAB-001
- AAIPharma
- Aastrom Biosciences
- AB Science
- Ab Sciex
- Abbie Celniker
- Abbott Laboratories
- Abbott Labs
- Abbott pharma
- AbCheck
- Abcodia
- AbCRO
- Abgenix
- Abingdon Life Sciences
- Abiomed
- abiraterone
- Ablynx
- Abraxane
- Abraxis BioScience
- Abraxis Health
- Abraxis Pharmaceutical
- ABSORB
- ABT-894
- ABthrax
- AC Immune
- Acacia Pharma
- academic partnership
- Acadia Pharmaceuticals
- ACAM2000
- Acambis
- Acanya
- ACC-001
- Accelerator Corporation
- Acceleron
- Accelovance
- Accelrys
- Accentia Pharmaceuticals
- Accenture
- Accera
- Access Pharmaceuticals
- Accupril
- ACE-011
- ACE-031
- ACE-536
- Acell
- AcelleRX Therapeutics
- AcelRx
- Acetavance
- Acetylon Pharmaceuticals
- ACH-1625
- Achaogen
- Achillion
- Achillion Pharmaceuticals
- ACHN-490
- Aciont
- Aclasta
- aclidinium bromide
- acne
- acomplia
- Acorda Therapeutics
- ACP-104
- ACP-106
- Acrux
- ACT Biotech
- actavis
- Actavis Totowa
- Actelion
- Actemra
- Actient Pharmaceuticals
- Actimis
- Activaero
- Active Biotech
- ActoGenix
- Actos
- ACU-4492
- Acucela
- Acura Pharmaceuticals
- Acurian
- Acurox
- Acusphere
- acute lymphoblastic leukemia
- Acute Myeloid Leukemia
- Acuvax
- ACX10061
- ACZ885
- AD 337
- Adamas Pharmaceuticals
- Adamis
- Adams Respiratory
- Adaptimmune
- Adaptive TCR
- Adasuve
- Adcetris
- AdcockIngram
- Adderall
- Addex Pharmaceuticals
- addiction
- Addrenex Pharmaceuticals
- Adenosine Therapeutics
- Adeona Pharmaceuticals
- Aderis Pharmaceuticals
- ADH-1
- ADHD
- ADHD patch
- Adherex
- Adimab
- Adipothermics
- adipotide
- adjuvant
- ADL5747
- ADL5859
- Adlea
- Adnexus Therapeutics
- Adolor
- Adrian Adams
- Adriana Jenkins
- adult stem cells
- Aduro BioTech
- AdVac
- Advagraf
- Advair
- Advanced Accelerator Applications
- Advanced Cell Diagnostics
- Advanced Cell Technology
- Advanced Clinical
- Advanced Life Sciences
- Advanced Viral Research
- Advancis Pharmaceutical
- AdvanDx
- Advaxis
- advent
- Advent Venture Partners
- ADVENTRX Pharmaceuticals
- adverse events
- Advexin
- Advinus
- Advion BioServices
- ADX10059
- Aegerion Pharmaceuticals
- Aegis Therapeutics
- AEGR-733
- Aeolus Pharmaceuticals
- Aeras
- Aerie Pharmaceuticals
- AeroLEF
- Aerovance
- Aerovant
- Aerpio Therapeutics
- AesRx
- AEterna Zentaris
- AEZS-108
- Affectair
- Affimed Therapeutics
- Affitech Therapeutics
- Affomix
- Affymax
- Affymaxm
- affymetrix
- Afinitor
- Aflibercept
- afluria
- AFM 13
- Afresa
- Afrezza
- Africa
- AG1000
- AG200-15
- Aganocide
- age related macular degeneration
- Agendia
- Agennix
- Agensys
- Agenus
- Aggrastat
- AGI Therapeutics
- AGI-1067
- Agile Therapeutics
- Agilent Technologies
- Aging
- Agios Pharmaceuticals
- Agros Therapeutics
- AiCuris
- Aidan King
- AIDSVAS
- Aileron Therapeutics
- AirStrip Technologies
- AkaRx
- Akaza Research
- AKB-6548
- Akebia
- Akebia Therapeutics
- Akela Pharma
- Akesis Pharmaceuticals
- Akikin Pharmaceuticals
- Akorn
- AKR-501
- Akrimax Pharmaceuticals
- Akten
- Akzo Nobel
- Alan Auerbach
- Alan Frazier
- Alan Levin
- Alan Trounson
- Alba Bioscience
- Alba Therapeutics
- Albany Molecular Research
- Albert Einstein College of Medicine
- Albuferon
- alcohol dependence
- Alcon
- ALD518
- Aldagen
- Alder Biopharmaceuticals
- Alectos
- Alemtuzumab
- Alessandro Banchi
- Alethia Biotherapeutics
- Alex Azar
- Alex Denner
- Alex Gorsky
- Alexander Denner
- Alexander Fleming
- Alexandria Real Estate
- Alexion Pharmaceuticals
- Alexis Borisy
- Alexza Pharmaceuticals
- Alfa wasserman
- Alfacell
- Algeta
- Alimera Sciences
- Alimta
- Alios BioPharma
- Alizyme
- ALK
- Alkermes
- ALKS 6931
- Allan Bradley
- Allena Pharmaceuticals
- Allergan
- allergies
- Allergy Therapeutics
- alli
- AlloCure
- Allon Therapeutics
- Allos
- Allostera Pharma
- allosteric modulators
- Allozyme
- Allozyne
- Allyson Schwartz
- Almac Group
- Almirall
- almorexant
- ALN-PCS
- ALN-VSP02
- Alnara Pharmaceuticals
- alnylam
- Alnylam Pharmaceuticals
- alogliptin
- Alopexx
- Alpha Innotech
- AlphaGenix
- Alpharadin
- Alpharma
- AlphaRx
- AlphaVax
- ALS
- ALS Therapy Development
- ALS-357
- Alseres Pharmaceuticals
- Alta Partners
- Altabax
- Altair
- altana
- Altea Therapeutics
- AltheaDx
- Altheos
- AltheRx
- Altor BioScience
- Altus Pharmaceuticals
- ALVAC
- alvimopan
- Alvine Pharmaceuticals
- Alzheimer's
- Alzheimer's disease
- Alzhemed
- AM-Pharma
- AM240 MCR
- AMAG Pharmaceuticals
- Amakem
- Amalyte Pharmaceuticals
- Amarin
- Amaya
- Amazon
- AmbioPharm
- Ambit Biosciences
- Ambrilia Biopharma
- Ambrx
- American Association for Cancer Research
- American Cancer Society
- American Medical Association
- American Regent
- AmerisourceBergen
- AMG 145
- AMG 479
- AMG 785
- Amgen
- Amicus Therapeutics
- Amir Nashat
- Amira
- amonafide
- Amoxicillin
- Ampio
- Ampligen
- Amplimed
- Ampyra
- AMR Technology
- AMR101
- AMRI
- amrubicin
- Amsterdam Molecular Therapeutics
- Amulet Pharmaceuticals
- Amylin pharmaceuticals
- amyloid beta
- amyotrophic lateral sclerosis
- Amyris Biotechnologies
- Amyvid
- AN2690
- ANA598
- ANA773
- ANA975
- anacetrapib
- Anacor Pharmaceuticals
- Anadys Pharmaceuticals
- analysts
- AnaMar Medical
- Anaphore
- anaplastic large cell lymphoma
- Anaptys Biosciences
- Anascorp
- AnC Bio
- Anchor Therapeutics
- Anders Ekblom
- Andreas Struengmann
- Andrew von Eschenbach
- Andrew Witty
- Andrin Oswald
- AndroScience
- Androxal
- Andrx
- Anemia drugs
- Anergis
- Anesiva
- Aneustat
- angina
- Angiocept
- angiodema
- Angiomax
- Angion Biomedica
- Angiotech Pharmaceuticals
- Angiotensin
- anidulafungin
- Anika Therapeutics
- Animal health
- Animal Liberation Front
- animal rights activists
- animal testing
- Ann Arbor
- Anna Protopapas
- Annalisa Jenkins
- Anne Wojcicki
- Anormed
- Answerthink
- Antares Pharma
- Anthera
- anthrax
- anthrax vaccine
- anti-addiction
- anti-counterfeiting
- anti-pain drug
- Anti-TNF
- antibacterial
- antibiotic
- antibodies
- Antibody 806
- anticoagulant
- antidepressant
- antigen
- Antigen Discovery
- Antigen Express
- Antigenics
- antisense
- Antisense Pharma
- Antisoma
- antithrombotic theory
- antiviral drug
- Anturol
- ANX-514
- ANX-530
- anxiety
- AP23573
- Apath
- apaziquone
- APD125
- Apeiron Biologics
- apes
- Apex Bioventures
- Apexigen
- APF530
- Aphios
- Apitope Technology
- apixaban
- Aplenzin
- ApoA-I Milano
- Apogenix
- Apoptone
- Apotex
- Apple
- Applied Biosystems
- Applied Genetic Technologies Corporation
- AppTec
- apremilast
- Apridra
- APT Pharmaceuticals
- Aptiv Solutions
- Aptuit
- Aquinox
- AQX-1125
- Aradigm
- Aragon Pharmaceuticals
- Arana Therapeutics
- Aranesp
- Aratana Therapeutics
- ARC16
- ARCA
- Arcalyst
- ARCH Venture Partners
- Archemix
- Archer Pharmaceuticals
- Archimedes
- Arcion Therapeutics
- Arcutis
- Arcxis Biotechnologies
- Ardana
- Ardea BioSciences
- Arecor
- Arena Pharmaceuticals
- Arete Therapeutics
- arGEN-X
- Argenta
- arGentis
- Arginetix
- Argolyn Bioscience
- Argonne National Laboratory
- Argos Therapeutics
- ARIAD Gene Therapeutics
- Ariad Pharmaceuticals
- Ariana Pharma
- Aridol
- Arigene
- Arikace
- Aris Global
- Arius
- Arizona
- Arizona State University
- Ark Therapeutics
- Arlene Chiu
- ARN-509
- Arno Therapeutics
- Arnold Schwarzenegger
- Arpida
- ARQ 197
- ArQule
- Array BioPharma
- Arriva
- Arrow Group
- Arrow International Limited
- Arrowhead Research
- Arrrogene
- ARRY-162
- ARRY-403
- ARRY-575
- arsalan arif
- Arsanis
- ART-123
- ART104
- ART621
- Arteaus Therapeutics
- arthritis
- Arthur Higgins
- Arthur Levinson
- artificial pancreas
- ARX
- ARX-01
- ARX424
- Aryx Therapeutics
- Arzerra
- arzoxifene
- AS1402
- AS1404
- ASA404
- Asahi Kasei Pharma
- Ascendis Pharma
- Ascent Therapeutics
- Ascenta Therapeutics
- Ascletis
- ASCO
- ASCO 2009
- ASCO 2010
- Asenapine
- Asentar
- Asia
- Aspen Pharmacare
- Aspen Technology
- Asphelia Pharmaceuticals
- Aspreva Pharmaceuticals
- asset sale
- assets
- AssureRx
- Astelin
- Astellas
- Astellas Pharma
- Astepro
- Asterand
- Astex Therapeutics
- asthma
- AstraZeneca
- Asuragen
- atacicept
- ataluren
- Athenagen
- Athera Biotechnologies
- Atherogenics
- Atherosclerosis
- Athersys
- Atlantos
- Atlas Genetics
- Atlas Venture
- Aton Pharma
- Atria
- atrial fibrillation
- Atritech
- Atrium Innovations
- ATryn
- ATS907
- Atu027
- AtuRNAi
- ATX-101
- aTyr Pharma
- Aubagio
- Aubrey de Grey
- Aura BioSciences
- Auriga Laboratories
- Aurigene
- Auspex Pharmaceuticals
- Australia
- Australian National University
- AutekBio
- Autifony Therapeutics
- autism
- AutoImmune
- autoimmune disease
- Auxilium Pharmaceuticals
- AV-299
- Avalon Pharmaceuticals
- avanafil
- Avandia
- Avanir Pharmaceuticals
- Avant Immunotherapeutics
- Avantome
- Avastin
- Avaxia
- Ave Maria Biotechnology
- AVE5530
- Avecia Biologics
- Aveed
- Avelox
- AVEO Pharmaceuticals
- Averion
- Avexa
- AVI Biopharma
- Avian Flu
- Avian flu vaccine
- Avid Biosciences
- Avid Radiopharmaceuticals
- AvidBiotics
- Avigen
- Avila Therapeutics
- AVL-292
- AVN316
- AVN994
- Avonex
- Avrio
- AX200
- Axanum
- Axcan Pharma
- Axentis Pharma
- Axial Biotech
- Axikin Pharmaceuticals
- Axiron
- axitinib
- AxoGen
- axomadol
- Axona
- AZ-002
- AZ-004
- AZD1446
- AZD3480
- AZD6244
- Azilect
- Azur Pharma
- BA058
- bacteria
- Bahija Jallal
- balaglitazone
- baldness therapies
- Balsalazide
- Baltimore
- Baminercept
- bankruptcy
- bapineuzumab
- Bar Harbor BioTechnology
- Barack Obama
- Baraclude
- BARDA
- bardoxolone
- Barr Pharmaceuticals
- Barrett's dysplasia
- Barrier Therapeutics
- Barry Marshall
- Bart Chernow
- basal cell carcinoma
- Basilea Pharmaceutica
- Battelle
- Bausch & Lomb
- Bavarian Nordic
- Bavituximab
- Baxter International
- Bayer
- Bayer AG
- Bayer Healthcare
- Bayer Schering
- Bayhill Therapeutics
- Bazedoxifene
- BCI-540
- BCX4208
- BD
- BDSI
- Beckman Coulter
- Beike Biotech
- Belatacept
- Belgium
- belinostat
- Bellco Health
- Bellicum Pharmaceuticals
- Bellus Health
- Benaroya Research Institute
- Bend Research
- benign prostatic hyperplasia
- Benitec
- Benlysta
- Benson Tsang
- Bentley Pharmaceuticals
- Bepreve
- Berkely HeartLab
- Berna Biotech
- Bernard Munos
- Bernard Poussot
- Betagenon
- Betaseron
- betrixaban
- bevirimat
- Bexsero
- Bextra
- BG Medicine
- BG-12
- BGC 945
- BGI
- Bial
- bicifadine
- Bidil
- Bifeprunox
- Big Biotech
- Big Pharma
- BigDNA
- Bilcare
- Bill and Melinda Gates Foundation
- Bill Andrews
- Bill Weldon
- Bill Wells
- Billionaire
- BIND Biosciences
- Binocrit
- Bio-Path Holdings
- Bioalliance Pharma
- BioAssets
- BioBAT
- BioCancell
- Biocartis
- BioChemics
- BioClinica
- Biocom
- BioComp Pharma
- Biocompatibles International
- Biocon
- BioCritica
- Biocryst
- BioCurex
- biodefense
- biodegradable regenerative stent
- Biodel
- BioDelivery Sciences
- BioDuro
- BioDuro Biologics
- Bioenvision
- BioFocus DPI
- Biogen Idec
- Biogenerics
- Bioheart
- bioinformatics
- BioInvent
- Bioject
- Biolex Therapeutics
- BiolineRx
- Biologics
- BioMarck Pharmaceuticals
- BioMarin Pharmaceutical
- biomarkers
- Biomarkers Consortium
- BioMed Central
- BioMed Realty
- biomedical research
- BioMedomics
- BioMerieux
- BioMimetic Therapeutics
- Biomira
- BioMolecular Therapeutics
- BioMS Medical
- BioNanomatrix
- BiondVax
- Bionest Partners Finance
- BioNexus
- Bioniche Life Sciences
- Bionomics
- Bionor Pharma
- BioNovo
- biopharm america
- biopharma industry
- biopharmaceutical company
- BioProcessors
- biopure
- BioSante Pharmaceuticals
- BioScale
- biosimilar
- biosimilars
- BioSpecifics Technologies
- BioSynthema
- Biota
- Biotec
- BIOTECanada
- biotech
- Biotech CEO
- Biotech CEO pay
- biotech company closing
- Biotech company news
- Biotech deals
- biotech drugs
- Biotech graveyard
- biotech growth
- biotech insider trading
- biotech investing
- Biotech investor
- Biotech IPO
- biotech jobs
- biotech news
- biotech patent news
- biotech revolution
- biotech salary
- Biotech spenders
- Biotech Stock
- biotech tax credit
- Biotech Venture Capital
- Biotech's Biggest Spenders 2011
- BiotechIT
- biotechnology
- biotechnology company
- Biotechnology Industry Organization
- biotechnology research
- Biotechnology Value Fund
- biotechs
- Biotectid
- bioterror
- Biotest
- Biothera
- bioTheranostics
- BioThorpe
- Biotica Technology
- BioTie Therapies
- BioTime
- Biotron
- Biovail
- BiovaxID
- Biovest International
- BioVex
- bioVIGIL
- Biovitrum
- BioWa
- BioXell
- BiPar Sciences
- Bipolar
- Bipolar disorder
- birth control
- BIT225
- BL-1040
- BLA
- Black Box Warning
- Bladder Cancer
- Blaze Bioscience
- Blend Therapeutics
- blinatumomab
- blindness
- blockbuster
- blockbusters
- blood cancer
- blood clots
- blood pressure
- blood substitute
- Blubird Bio
- Blue Chip
- bluebird bio
- Blueprint Medicines
- BN ImmunoTherapeutics
- boceprevir
- Boda
- Boehringer Ingelheim
- Bohai
- bone cancer
- bone marrow
- Boostrix
- Bosatria
- Boston
- Boston Business Journal
- Boston Globe
- Boston Scientific
- Boston University
- bosutinib
- Botox
- Bradley Pharma
- Bradmer Pharmaceuticals
- brain
- brain cancer
- brain disease
- brain disorder
- Brain Plasticity
- brain tumor
- BrainCells
- Brainlab
- breast cancer
- Bremelanotide
- Brent Norton
- brentuximab vedotin
- Bridion
- Briggs Morrison
- Brigham and Women's Hospital
- Brilinta
- Bristol-Myers Squibb
- Broad Institute
- Bronchitol
- Brostallicin
- Bruce Boise
- Bryan Lawis
- Bryan Morton
- BSI-201
- BT-061
- BTG
- bucindolol
- Budesonide
- Buprenorphine
- Bush Administration
- business development
- Busulfex
- buyouts
- Bydureon
- Byetta
- C-TASC
- C.R. Bard
- C3i
- cabazitaxel
- cabozantinib
- Cadence Pharmaceuticals
- Cadila Healthcare
- Cadila Pharmaceuticals
- Calando Pharmaceuticals
- calcitonin
- Caliber Biotherapeutics
- Calibra
- California
- California Institute for Regenerative Medicine
- Caliper Life Sciences
- Calistoga Pharmaceuticals
- Calithera Biosciences
- Callisto Medical
- Caltech
- Calypso Medical Technologies
- Cam Garner
- Cambrex
- Cambria Biosciences
- Cambria Pharmaceuticals
- Cambridge
- cambridge antibody technology
- Cambridge Biotechnology
- Cambridge Company
- Cambridge Consultants
- cambridge massachusetts
- Campath
- Can-Fite BioPharma
- Canaan Partners
- Canaccord Capital
- Canada
- Canary Foundation
- Cancer
- Cancer Drugs
- cancer pain
- cancer research
- Cancer Research UK
- cancer stem cells
- Cancer Therapeutics CRC
- cancer therapies
- cancer vaccine
- Cancidas
- Cangene
- Cangene Biopharma
- cangrelor
- Cannabinoids
- Canopus BioPharma
- capital partners
- Capoxigem
- caprotec bioanalytics
- Capstone Therapeutics
- Cara Therapeutics
- Caraco Pharmaceutical Laboratories
- Carbaglu
- Cardene
- Cardio3 BioSciences
- Cardiology
- Cardiome Pharma
- cardiovascular
- Cardiovascular Biotherapeutics
- cardiovascular risks
- Cardioxyl Pharmaceuticals
- carfilzomib
- Cariprazine
- Carisbamate
- Carl Icahn
- Carlo Paribello
- Carlos Paya
- Carlyle Group
- Carmel Pharma
- Carol Gallagher
- Carrolee Barlow
- Carticept Medical
- Cascade ProDrug
- case studies
- Case Western Reserve University
- Castle Biosciences
- Catabasis Pharmaceuticals
- Catalent Pharma Solutions
- Catalyst Biosciences
- Catalyst Pharmaceutical
- Catapult Bio
- Catena
- Cato Research
- Cayston
- CD103
- CDC
- CDISC
- CDX-110
- Cebix
- Ceftaroline
- ceftobiprole
- Cel-Sci
- Celacade
- Celator
- Celator Pharmaceuticals
- Celebrex
- Celera
- Celgene
- celiac disease
- Cell Biosciences
- Cell Genesys
- Cell Signaling Technology
- cell signalling
- Cell Therapeutics
- CellCentric
- CellCept
- CellCyte
- Celldex Therapeutics
- Cellectis bioresearch
- Cellerant Therapeutics
- Cellerix
- cells
- Cellular Dynamics
- Cellzome
- Celsion
- Celtaxsys
- Celtic Pharma
- Celtic Pharma Management
- Celtic Therapeutics
- CEM-101
- CEM-102
- Cempra Pharmaceuticals
- Ceneris
- CeNeRx BioPharma
- Cenix BioScience
- Cenomed BioSciences
- Center for World Health & Medicine
- Centocor Ortho Biotech
- central nervous system
- Centre for Addiction and Mental Health
- CEP-37247
- Cephalon
- Ceplene
- Ception Therapeutics
- Cequent Pharmaceuticals
- CER-001
- Ceragenix Pharmaceuticals
- Cerebral vasospasm
- Ceregene
- Cerenis Therapeutics
- Cerepro
- Ceres
- Cerexa
- Cerezyme
- Certriad
- Cerulean Pharma
- Cerus
- Cervarix
- cervical cancer
- cervical cancer vaccine
- Cetero Research
- cethromycin
- CETP inhibitors
- Cetrorelix
- CEVEC Pharmaceuticals
- CFO
- CG Therapeutics
- CGI Pharmaceuticals
- Chad Therapeutics
- Champions Biotechnology
- Chandrix
- Charles Baum
- Charles Butt
- Charles Grassley
- Charles River
- Charles River Laboratories
- Chelsea Therapeutics
- ChemAxon
- ChemBridge
- ChemDiv
- ChemGenex
- ChemoCentryx
- ChemoFx
- Chemokine Therapeutics
- chemotherapy
- Chi-Med
- chief medical officer
- chief operating officer
- chief scientific officer
- Chiesi Farmaceutici
- Children's Hospital Boston
- Chile
- Chiltern International
- Chimerix
- China
- China Aoxing
- China National Biotech Group
- China Nuokang Bio-Pharmaceutical
- China Pharma Holdings
- China SFDA
- China SFDA approval
- China Sky One Medical
- China West
- Chinese Academy of Merical Sciences
- Chiron
- Chmp
- CHMP recommendation
- cholesterol
- cholesterol drug
- Chorus
- Chris Brinsmead
- Chris Newton
- Chris Stern
- Chris Viehbacher
- Christoph Westphal
- Christopher Spooner
- Christopher Viehbacher
- Christy Shaffer
- Chroma Therapeutics
- Chromatin
- Chromocell
- Chronic Idiopathic Constipation
- chronic lymphocytic leukemia
- chronic pain
- CHS Pharma
- Chugai
- Chutes and Ladders
- Cialis
- CIDP
- cilomilast
- Cimzia
- Cinquil
- Cinryze
- Cipher Pharmaceuticals
- Cipla
- Circassia
- Civitas Therapeutics
- CK-1
- CK-1827452
- CK-2017357
- cladribine
- clar
- claribine
- Clarient
- Clarimedix
- Claritin
- Clarus Therapeutics
- Clarus Ventures
- Class Action
- class I recall
- Clavis Pharma
- clazosentan
- CLC bio
- clean tech
- Clearside Biomedical
- ClearTrial
- Cleave Biosciences
- Cleveland Biolabs
- Cleveland Clinic
- Cleviprex
- clevudine
- Clinical Data
- Clinical Development
- clinical hold
- clinical tri
- Clinical Trial
- clinical trial design
- clinical trial management
- Clinical Trial Results
- Clinical Trials
- Clinipace Worldwide
- ClinPhone
- ClinPlus
- clivatuzumab tetraxetan
- Clive Dix
- Clive Morris
- Clolar
- cloning
- clostridium difficile
- Clovis Oncology
- CLSI
- Clyclacel
- Cmed Technology
- CN Creative
- CNTO 1275
- Coartem
- Coast IRB
- Cocrystal Discovery
- CoDa Therapeutics
- Codexis
- Cofactor
- Cogane
- Cogentus Pharmaceuticals
- Cognition Therapeutics
- Col-118
- Colazal
- Collaboration Agreement
- collaborations
- CollaGenex Pharmaceuticals
- CollaRx
- Collegium Pharmaceutical
- colon cancer
- Colorado
- colorectal cancer
- CoLucid Pharmaceuticals
- Columbia Laboratories
- Columbia University
- Columbia University Medical Center
- CombiMatrix
- combination
- Combinatorx
- combined company
- combo drug
- CoMentis
- commercialization
- Commercialization deals
- Commonwealth Biotechnologies
- companion diagnosics
- companion diagnostics
- comparative effectiveness
- Compass Biotechnologies
- competitors
- Complete Genomics
- Complete Response Letter
- Comprehend Systems
- Compugen
- Computer Model
- Conatus Pharmaceuticals
- Conbriza
- Concert Pharmaceuticals
- Concordia Pharmaceuticals
- Concordia University
- Conflict of interest
- Congress
- ConjuChem
- Connecticut
- Constellation Pharma
- construction
- Contingent value right
- continuous release
- contraceptive
- contract research organizations
- Contrave
- controlled release
- controlled release formulation
- controversy
- Convergence
- Convergence Pharmaceuticals
- Copaxone
- COPD
- Corcept Therapeutics
- CORDAPTIVE
- Cordex Pharma
- Cordis
- Coreg
- Corengi
- Corey Goodman
- Corgentech
- Coria Laboratories
- Coridon
- corifollitropin alfa
- Cork
- CorMedix
- Cornell
- Cornell university
- Cornerstone BioPharma
- Cornerstone Pharmaceuticals
- Cornerstone Therapeutics
- Coronado Biosciences
- coronary artery disease
- coronary stents
- Cortex Pharmaceutcials
- Corthera
- Corus Pharma
- CorVue
- Cotara
- Cougar Biotechnology
- counterfeit drugs
- Covagen
- Covance
- Covidien
- Cowen Healthcare Royalty Partners
- cox 2 inhibitor
- CP- 870
- CP-4126
- CP-690
- CP-945598
- CPC Scientific
- CPEX Pharmaceuticals
- CPP-109
- CPX-351
- CR014
- Craig Tooman
- Creabilis
- Crescendo Bioscience
- Crestor
- CRI
- Critical Path Initiative
- Critical Path Institute
- Critical Pharmaceuticals
- critical therapeutics
- critics
- CRIX
- crizotinib
- CRO
- Crohn's disease
- Crown Bioscience
- Crucell
- Cryo-Cell
- CRYSTAL study
- CrystalGenomics
- CSC
- CSL
- CT-011
- CTEP inhibitors
- CU-2010
- Cubicin
- Cubist Pharmaceuticals
- Cumberland Pharmaceuticals
- Curacyte
- curagen
- CureDM
- Curemark
- CureTech
- CureVac
- Curis
- Curosurf
- Curt Selquist
- Cushing's disease
- CV Therapeutics
- CV-301
- CVRx
- CX717
- CXL-1020
- Cyberkinetics
- cybrids
- Cyclacel
- Cycle Computing
- Cyclofluidic
- Cycloset
- Cydex Pharmaceuticals
- Cylene Pharmaceuticals
- Cymbalta
- Cyntellect
- Cypress Bioscience
- cystic fibrosis
- Cystic Fibrosis Foundation Therapeutics
- cystric fibrosis
- CYT003-QbG10
- CYT006-AngQb
- CYT387
- Cytel
- Cyterix
- Cytheris
- CytImmune Sciences
- Cytochroma
- CytoDyn
- CytoFab
- Cytogen
- CytoGenix
- cytokinetics
- Cytolin
- Cytomedix
- CytomX Therapeutics
- Cytopia
- Cytori Therapeutics
- Cytos Biotechnology
- Cytovance Biologics
- CytRx
- Czech Republic
- d center
- dacetuzumab
- daclizumab
- Dacogen
- Daiichi Sankyo
- Dainippon Sumitomo
- Dako
- dalbavancin
- dalcetrapid
- Daliresp
- Dan Dueber
- Dana-Farber Cancer Institute
- Danaher Corp
- Daniel Adams
- Daniel S. Goldberg
- Daniel Vasella
- Daniel Zurr
- Danisco BioActives
- danoprevir
- dapagliflozin
- Daphne Zohar
- DAR-311
- DARA BioSciences
- darapladib
- darexaban
- Darmstadt Germany
- darusentan
- data monitoring committee
- Datatrak
- Dave Ricks
- Dave Urdal
- David Baltimore
- David Bredt
- David Brennan
- David Ebersman
- David Eveleth
- David Ginsberg
- David Heimbrook
- David Holveck
- David Hung
- David Mackney
- David Mazzo
- David Mott
- David Murdock
- David Nance
- David Pritchard
- David Schenkein
- DaVinci Biosciences
- Daxas
- Daytrana
- DBV Technologies
- deal
- Deb Dunsire
- Debio 025
- Debiopharm
- Debiovision
- Deborah Autor
- Deciphera Pharmaceuticals
- Decision Resources
- DecisionView
- Decode Genetics
- defibrotide
- deforolimus
- Degarelix
- degludec
- Deirdre Connelly
- Delaware
- Delcath
- Delenex Therapeutics
- delisting
- Delsite
- Deltanoid
- Democrats
- Dendreon
- dendrimer
- Dengue fever
- Denmark
- Dennis Goldberg
- Denosumab
- Denver
- Department of Defense
- Department of Health and Human Services
- Department of Justice
- DepoDur
- Depomed
- depression
- Derica Rice
- Derma Sciences
- DermaTech
- Dermira
- Desmoteplase
- Deval Patrick
- development costs
- Development deals
- Devgen
- DexCom
- DIA
- DIA 2009
- Diabetes
- Diaceutics
- DiaGenic
- Diagnoplex
- diagnosics
- diagnostics
- Diakron Pharmaceuticals
- Diamyd
- Diasome Pharmaceuticals
- Diatos
- Dicerna Pharmaceuticals
- Dificid
- Difluprednate
- Digna
- Dimebon
- Dimera
- Dinakar Singh
- DiObex
- Diractin
- Direvo Biotech
- dirucotide
- Disclosure
- DiscoveRx
- Discovery Laboratories
- Discovery Labs
- diseases of aging
- Distribution deal
- DMI BioSciences
- DNA
- DNA Ink
- Dna Sequencing
- DNA Therapeutics
- DNage
- DNAnexus
- doctors
- dolutegravir
- Domain Associates
- Domain Therapeutics
- donepezil
- dopamine
- Dopexamine
- Dor BioPharma
- Doribax
- Douglas Squires
- Douglas Williams
- Dov Pharmaceutical
- Dow Pharmaceutical Sciences
- Down syndrome
- Doxil
- DPP-4 inhibitors
- DR Cysteamine
- Dr. Margaret Hamburg
- Dr. Patrick Soon-Shiong
- Dr. Reddy's
- Dr. Steven Nissen
- Draper Laborator
- Drew Faust
- Droxidopa
- Drug approvals
- drug candidates
- drug combination
- drug data
- drug delivery
- drug delivery gel
- drug delivery systems
- drug delivery technology
- drug developer
- Drug Development
- Drug Discovery
- Drug Efficacy
- drug formulation
- drug marketing
- drug names
- drug prices
- Drug repositioning
- drug reprofiling
- Drug Resistance
- Drug Safety
- drug shortage
- drug targets
- Drug Trials
- drug-eluting stents
- Drug-Induced Human Liver Injury
- Drugs for Neglected Diseases Initiative
- DSM Biologics
- DTC advertising
- Duchenne muscular dystrophy
- Duke University
- Dulera
- Duramed Pharmaceuticals
- Durect
- Dusa Pharmaceuticals
- Duska Therapeutics
- dutogliptin
- DVS Sciences
- DX-88
- Dyadic
- Dyax
- Dyloject
- Dynavax Technologies
- Dynogen
- dysmenorrheal
- Dysport
- DZS Software
- e-Therapeutics
- E.coli
- E10030
- E5555
- Eagle Genomics
- earnings
- Eastern Europe
- eBioscience
- Ebola Hemorrhagic Fever
- ecallantide
- Echo Therapeutics
- ECLIPSE study
- Eco Therapeutics
- Economic development
- eculizumab
- Eddingpharm
- EDEN Bioscience
- Edge Therapeutics
- Edluar
- Edurant
- Edward Mascioli
- efalizumab
- efavirenx
- Effient
- EffRx
- Egg-based
- Eiger BioPharmaceuticals
- Eisai
- EKR Therapeutics
- elacytarabine
- Elafin
- elagolix
- Elan
- Elbion
- Election 2008
- electronic health records
- elesclomol
- Elevation Pharmaceuticals
- Eleven Biotherapeutics
- Eli and Edythe Broad
- Eli Lilly
- Elias Zerhouni
- Eliassen Group
- Eligard
- elinogrel
- Eliquis
- Elite Pharmaceuticals
- Elitra Pharmaceuticals
- Elixir Pharmaceuticals
- Elizabeth Dragon
- Elk Run
- Ella
- Ellen McDonald
- Elliot Sigal
- ELND005
- elotuzumab
- Elton John
- Elusys Therapeutics
- elvitegravir
- Embeda
- Ember Therapeutics
- Embera NeuroTherapeutics
- embryonic stem cells
- EMC
- EMD Millipore
- EMD Serono
- EMEA
- EMEA application
- EMEA Approval
- EMEA recommendation
- Emergent BioSolutions
- Emerging Drug Developer
- Emerging Healthcare Solutions
- emerging markets
- emerging outsourcing trends
- EmergingMed
- Emisphere
- EMO-FARM
- Empatic
- Emtriva
- En Li
- Enanta
- Enbrel
- Encore Therapeutics
- Encorium Group
- Encysive
- Endeavor
- Endo Pharmaceuticals
- Endocyte
- endometriosis
- Enlight Biosciences
- Enobia Pharma
- Ensemble Discovery
- Entelos
- Entereg
- EntreMed
- Entrepreneur
- EnVivo
- Envoy Therapeutics
- Enzo Biochem
- Enzon Pharmaceuticals
- Enzymatic Therapy
- Enzymotec
- Eon Labs
- Epeius Biotechnologies
- ePharmaSolutions
- EpiCept
- EpiCeram
- epigenetics
- epilepsy
- Epistem
- Epitomics
- EPIX Pharmaceuticals
- Epixis
- Epizyme
- Epogen
- Epratuzumab
- eprotirome
- Eprova
- Equasym
- equity investment
- EraGen Biosciences
- Erbitux
- erectile dysfunction
- eribulin
- Eric Lander
- ERT
- Erythema
- Erythropoietin
- ES Cell International
- ESBATech
- escallantide
- ESI Florida
- esophageal cancer
- Esperance
- Esperion Therapeutics
- Esprit Pharma
- Esreboxetine
- Essentialis
- Essex Woodlands
- Eszopiclone
- etanercept
- EU
- Euclid Systems
- Eugene Melnyk
- Eurand
- Eureka Genomics
- Europe
- European Commission
- EUSA Pharma
- Euthymics Bioscience
- EvaMist
- Evan Levine
- Everolimus
- Evista
- Evoke Pharma
- Evolva
- Evonik
- Evotec
- EVT 101
- EVT 103
- EVT 201
- EX101
- EXACT Sciences
- Exalgo
- EXC 001
- Excaliard Pharmaceuticals
- Excalibur
- Excel PharmaStudies
- Excelimmune
- Executives
- Exelbine
- Exelisis
- Exelixis
- exenatide
- Exeter Life Sciences
- Eximias
- Exiqon
- ExonHit Therapeutics
- Exparel
- ExpeData
- Experimental Drugs
- experimental therapy
- expert advice
- Extab
- Exubera
- EyeCyte
- Eyegate
- EyeSense AG
- Eyetech
- Eylea
- f-star
- F2695
- Fablyn
- Fabrazyme
- Facet Biotech
- factive
- Faheem Hasnain
- Failed drug program
- fampridine
- Famvir
- Fanapt
- FASEB Journal
- FASgen
- Fast Forward
- Fast Track designation
- Fate Therapeutics
- fatostatin
- Fauci
- Favrille
- FCB-Pharmicell
- FDA
- FDA application process
- FDA approvable letter
- FDA approval
- FDA approval & regulation
- FDA delay
- FDA expert panels
- FDA investigation
- FDA priority review
- FDA quality certification
- FDA recommendation
- FDA refuse-to-file letter
- FDA regulation
- FDA rejection
- FDA response letter
- FDA review
- FDA update
- FDA warning
- febit
- federal funding
- federal judge
- female sexual dysfunction
- Femara
- FemiFect
- Femta
- Fentora
- Fereydoun Firouz
- FermaVir
- Ferring Pharmaceuticals
- Ferring Pharmaceuticals A/S
- FerroKin Biosciences
- fertility
- ferumoxytol
- festinavir
- fetal gender
- Fibrocell Science
- FibroGen
- Fibromyalgia
- fidaxomicin
- Fidia Farmaceutici
- FIELD study
- Fierce 15
- fierce clinical trials
- fierce15
- figitumumab
- Filgrastim
- financial reports
- finasteride
- fipamezole
- Firazyr
- Firebird
- FirstPoint Biotech
- fish oil
- Fisher Scientific
- Five Prime Therapeutics
- FKD Therapies
- Flagship Biosciences
- Flagship Ventures
- Flamel
- Flemming Lindeløv
- Flex Biomedical
- Flexible Stenting Solutions
- Flexion Therapeutics
- flibanserin
- Florida
- flu
- flu vaccine
- FluBlok
- Fluidigm
- Flumist
- Fluorotechnics
- Flurizan
- Flutiform
- FMD Report
- FoldIt
- FoldRx Pharmaceuticals
- Follica
- Folotyn
- foot-and-mouth
- Foradil
- Forbes Medi-Tech
- Forbion Capital Partners
- Forest Laboratories
- Forma Therapeutics
- Formac Pharmaceuticals
- Formatech
- ForSight VISION4
- ForteBio
- Fortesta
- Forward Ventures
- fospropofol disodium
- fostamatinib
- Foundation Medicine
- Fountain Healthcare Partners
- Fovea Pharmaceuticals
- FP-1039
- Fragile X Research
- France
- France Biotech
- Francis Collins
- Frank Baldino
- Frank Callahan
- Franz Humer
- Fred Eshelman
- Fred Hassan
- Friedreich's Ataxia
- Frova
- fruit fly
- fruts and vegetables
- FT1050
- FTC
- FTY720
- Fujifilm
- funding
- funding gap
- Furiex
- Fusilev
- FV-100
- GA101
- Gabapentin GR
- Gabriel Sciences
- Gail Schulze
- Galantamine Hydrobromide
- Galantos Pharma
- Galapagos
- Galderma
- Galena BioPharma
- Galenea
- Galenica
- Galleon
- Galleon Pharmaceuticals
- Gallus Biopharmaceuticals
- galvus
- Gamma Therapeutics
- Gammagard
- Gamunex
- ganitumab
- gantenerumab
- Ganymed Pharmaceuticals
- GAO
- Gardasil
- Garnet Biotherapeutics
- Garo Armen
- Garry Nicholson
- Gary Reys
- Gary Shearman
- gastroparesis
- Gattex
- GAVI
- GDC-0449
- GDC-0941
- GDC-0973
- GE
- GE Healthcare
- Gedeon Richter
- Gelesis
- gemcitabine
- Gemin X Pharmaceuticals
- Gen-Probe
- Genaera
- Genasense
- Gencaro
- gene expression
- Gene Logic
- gene mutation
- gene sequencing
- gene targeting
- gene therapy
- Genechem
- Genedata
- Genelabs Technologies
- GeneNews
- GeneNews Limited
- Genentech
- general counsel
- General Electric
- GeneraMedix
- Generex
- Generic
- Generic Biologics
- Generics
- genes
- Genesis Pharmaceuticals
- GeneThera
- genetic model
- genetic mutation
- genetic resistance
- genetic sequencing
- genetic test
- Genetically Engineered Animals
- genetics
- Genetix Pharmaceuticals
- GENFIT
- genital warts
- Genitope
- Genizon
- GenMab
- GeNO
- Genocea Biosciences
- GenoLogics
- Genomatica
- Genomatix
- Genome
- Genomic Health
- Genomic Vision
- Genomics
- Genoptix
- GENova Biotherapeutics
- GenSpera
- Genta
- Gentium
- Genvec
- Genway Biotech
- Genyous Biomed
- Genzyme
- GeoPharma
- George Church
- George Scangos
- Georges Gemayel
- Georgia
- GeoVax
- Gerard Le Fur
- Gerard Martino
- German Cancer Research Center
- Geron
- Gestiva
- GI-4000
- GI-5005
- gIcare
- gifts
- Gilead Sciences
- Gilenia
- Gilenya
- GIMV
- Ginkgo Bioworks
- Gino Santini
- GIST
- Gladstone Institutes
- glaucoma
- GlaxoSmithKline
- Gleevec
- Glenmark Pharmaceuticals
- Glenn Gormley
- GLG Pharma
- Glide Pharma
- glioblastoa
- glioblastoma
- gliomas
- Global Health Ventures
- globalization
- GlobeImmune
- Gloucester Pharmaceuticals
- GLPG0259
- glucose monitoring system Type 1 diabetes
- Glumetza
- Glybera
- Glybera pancreatitis
- GlycArt
- GlycoMimetics
- GlycoVaxyn
- Glyn Edwards
- GM Biopharmaceuticals
- going concern warning
- Goldmans Sachs
- Golimumab
- Google Ventures
- Gordon Brown
- Gordon Wier
- gout
- Gov. Christine Gregoire
- GPC Biotech
- GPCR
- Graceway Pharmaceuticals
- Graffinity Pharmaceuticals
- Graham Cooper
- Grazax
- GRC 6211
- green initiatives
- Gregory Lucier
- Grifols
- GRNOPC1
- GrowthWorks
- Grupo Ferrer
- GS 9191
- GS9411
- GSK
- GSK-299423
- GSK1838262
- GSK2118436
- GTC Biotherapeutics
- GTCR Golder Rauner
- GTx
- GV1001
- GVAX immunotherapy
- GVK Biosciences
- GW Pharma
- GW Pharmaceuticals
- GWAS
- Gwen Krivi
- Gwen Melincoff
- Gyros
- H. Lundbeck
- H. Stewart Parker
- H1N1
- H3 Bioscience
- H5N1
- HAART
- HAE
- Haemacure
- Halaven
- Halo Pharmaceutical
- Halozyme
- Hana Biosciences
- Handok Pharmaceuticals
- Hank McKinnell
- Hanwha Chemical
- Haptogen
- Harbor BioSciences
- Harlan Waksal
- Harold Varmus
- Harry Stylli
- Hartfort Hospital
- Harvard
- Harvard Medical School
- Harvard University
- Hatteras Venture Partners
- Hawaii Biotech
- HB101
- HBM Bioventures
- HCD122
- HCV NS5A
- HDAC
- HDLS
- HE3235
- head and neck cancer
- head and neck cancers
- Head Lice
- Healive
- Health Canada
- Health Canada approval
- Health Decisions
- Health Market Science
- healthcare reform
- Healthcare Ventures
- HealthLinx
- hearing
- heart disease
- heart drug
- Helical Sciences
- Helicon Therapeutics
- Helicos BioSciences
- Helix BioMedix
- Helix Biopharma
- Helixis
- Helmholtz Zentrum München
- Helsinn
- HemaQuest Pharmaceuticals
- Hematech
- Hematide
- Hemispherx Biopharma
- Hemo-Stream
- hemophilia
- Hemopure
- Henri Termeer
- Henri and Belinda Termeer Center for Targeted Therapies
- Henri Termeer
- Henry E. Blair
- Henry Waxman
- HepaLife Technologies
- Heparin
- Hepartes
- hepatitis B
- Hepatitis C
- hepatitis E
- Hepatoren
- Heplisav
- Hepregen
- Heptares Therapeutics
- Herceptin
- hereditary angieoedema
- Heritage Pharmaceuticals
- Hesperion
- High Throughput Genomics
- Highland
- Highland Capital Partners
- Hillary Clinton
- HIPAA
- Hirofumi Onosaka
- Hisamitsu Pharmaceutical
- Histogen
- Histogenics
- HIV
- HIV/AIDS
- HIV/HBV
- Hodgkin's lymphoma
- Hollis-Eden Pharmaceuticals
- Hookipa Biotech
- Hopen Life Science Ventures
- Horizant
- Horizon Therapeutics
- Hospira
- Hospital del Mar
- hostile takeover
- Hovione
- Howard Richman
- HPN-100
- HRA Pharma
- Hubert Birner
- Human African Tryanosomiasis
- Human Genetic Therapies
- Human Genome Sciences
- human growth hormone
- human research
- Humana
- Humanetics Corporation
- HuMax CD-20
- HuMax-EGFr
- Humedica
- Humira
- Hunter Immunology
- Huntingdon Life Sciences
- Huntington's
- HUYA Bioscience
- HVC-796
- Hwang Woo-suk
- hybrid
- Hycamtin
- Hydra Biosciences
- HyperAcute Pancreas
- Hyperion Therapeutics
- hypertension
- hypoactive sexual desire disorder
- hypoglycemia
- HZT-501
- Ian Garland
- Ian Read
- IASO Pharma
- iBioPharma
- Ibis Biosciences
- Ibis T5000
- IBM
- Ibraheem Mahmood
- ICA-105665
- Icagen
- iCardiac Technologies
- icatibant
- Ichor Medical Systems
- iclaprim
- iCo Therapeutics
- ICON
- Iconix Biosciences
- IDEA
- Idenix Pharmaceuticals
- Idera
- Idera Pharmaceuticals
- IDM Pharma
- IDX184
- IDX320
- IDX899
- Igenica
- IK-1001
- Ikano Therapeutics
- Ikaria
- Ikonisys
- Ilaris
- Illumina
- iloperidone
- Iluvien
- Ilypsa
- Imagen
- imaging
- ImaRX Therapeutics
- IMC-1121B
- IMC-11F8
- IMC-A12
- ImClone
- Imitrex
- immatics
- Immtech Pharmaceuticals
- Immune Design
- immune response
- immune system
- ImmuneRegen BioSciences
- Immuno-Designed Molecules
- ImmunoCellular Therapeutics
- Immunocore
- ImmunoGen
- Immunomedics
- ImmunoSolv
- Immunosyn
- ImmunoVaccine Technologies
- immununotherapy
- ImmuPharma
- ImmusanT
- Immutep
- IMO-2055
- IMO-3100
- IMPACT study
- IMPAX
- Impax Labs
- Impax Pharmaceuticals
- IMPLANET
- Implicit Bioscience
- IMS Health
- Imvamune
- IN 105
- INC Research
- Inc.
- INC424
- INCB18424
- INCB28050
- INCB28060
- Incivek
- Incline Therapeutics
- Inclinical
- Incyte
- Incyte Corporation
- IND
- indacaterol
- Independent Pharmaceutica
- Indevus Pharmaceuticals
- Index Ventures
- India
- Indiana
- Indiana University
- indication
- IndiPharm
- Indonesia
- Industry Voices
- Inex Pharmaceuticals
- InfaCare Pharmaceutical
- infectious diseases
- Infinity
- Infinity Pharmaceuticals
- inflammation
- inflammatory bowel disease
- inflammatory conditions
- inflammatory diseases
- influentials
- Informatics
- infrared light
- Ingenuity Systems
- inhalation
- inhaled drug delivery
- Inhibitex
- iniparib
- injectable
- Inlyta
- Innate Pharma
- InNexus Biotechnology
- Innocoll
- Innogenetics
- Innopharm
- innovation
- Innovatis
- Innovative Medicines Initiative
- INNOVIVE Pharmaceuticals
- INO-4885
- INO-8875
- Inotek Pharmaceuticals
- Inovio
- InSite One
- InSite Vision
- Insmed
- insomnia
- Inspiration Biopharmaceuticals
- Inspire Pharmaceuticals
- Instem
- insulin
- insulin pump
- insurance companies
- INT-747
- INT-777
- Intanza
- Intas
- Integral Molecular
- Integrated Biopharma
- Integrated Biotherapeutics
- Intelect Medical
- Intelence
- IntelGenx
- Intellect Neurosciences
- Intelliject
- Intellikine
- IntelliPharmaCeutics
- Intercell
- Intercept Pharmaceuticals
- Intercytex
- interferon
- Intermezzo
- Intermune
- International Stem Cell Corp
- Interphex
- Intertech Bio
- InterWest Partners
- Intra-Cellular Therapeutics
- Intradigm
- Intranasal Therapeutics
- Intrexon
- Introgen Therapeutics
- inVentiv
- investigation
- investigators
- investment
- Inviragen
- Invitrogen
- Invus
- INX-189
- IoGen
- Iomai
- Ionsys
- Iorcaserin
- IP
- IPI-493
- IPI-504
- IPI-926
- iPieran
- iPierian
- ipilimumab
- Iplex
- IPO
- IPSC
- Ipsen
- Ipsogen
- IPX066
- Ireland
- IRES technology
- Iressa
- irisin
- Iroko Cardio
- Iroko Pharmaceuticals
- Ironwood Pharmaceuticals
- Irritable Bowel Syndrome
- IRX Therapeutics
- IS Pharma
- isavuconazole
- ischemia
- Isconova
- Isentress
- ISI
- ISIS 301012
- ISIS 388626
- Isis Pharmaceuticals
- iSoft
- Isolagen
- Isotechnika
- Israel
- ISTA Pharmaceuticls
- Istodax
- Italy
- Itero Biopharmaceuticals
- ITI Life Sciences
- IXEMPRA
- iZumi Bio
- J. Craig Venter
- J. Michael Pearson
- Jack Lief
- JADO Technologies
- JAK inhibitors
- James Bianco
- James Cornelius
- James Greenwood
- James Mullen
- James S. Kuo
- James Shannon
- James White
- Jan Lundberg
- Jan van de Winkel
- Janssen
- Janumet
- Januvia
- Japan
- Japan Tobacco
- jassen
- Javelin Pharmaceuticals
- Javier San Martin
- Jazz Pharmaceuticals
- Jérôme Contamine
- JDS Pharmaceuticals
- Jean Stéphenne
- Jean-Claude Leroy
- Jean-Luc Belingard
- Jean-Marc Huet
- Jean-Paul Clozel
- Jean-Pierre Garnier
- Jeffrey H. Buchalter
- Jeffrey Kindler
- Jeffrey Leiden
- Jennerex
- Jens Eckstein
- Jeremy Levin
- Jerini
- Jerusalem
- Jexys Pharmaceuticals
- JHP Pharmaceuticals
- Jiangbo Pharmaceuticals
- Jim Greenwood
- Jim Kerstetter
- Jinfiniti Biosciences
- Jinzi J. Wu
- JLL Partners
- job cuts
- Joe Bolen
- Joe Jimenez
- Joel Lexchin
- John Babich
- John C. Martin
- john carroll
- John Dyer
- John Johnson
- John Knopf
- John LaForge
- John LaMattina
- John Lechleiter
- John Maraganore
- John McCain
- John Milligan
- John Oyler
- John P. Longenecker
- John P. Walker
- John Patterson
- John Scarlett
- Johns Hopkins
- Johns Hopkins University School of Medicine
- Johnson & Johnson
- Joicela
- joint venture
- Jolee Mohr
- Jon P. Stonehouse
- Jon Symonds
- Jose Carlos Gutierrez-Ramos
- Joseph Jimenez
- Joseph Yanchik
- Joshua Boger
- Joshua Sharfstein
- Joslin Diabetes Center
- Journal of the American Medical Association
- JPM12
- JTT-305
- Jubilant Biosys
- Juergen Ernst
- Julie Overbaugh
- JUPITER study
- Justiva
- Juvaris BioTherapeutics
- Juventas Therapeutics
- Juvista
- Juvisync
- JVRS-100
- JX-594
- JZP-4
- JZP-6
- JZP-7
- K-RAS gene
- Kadmon I LLC
- KAEL GemVax
- KAI Pharmaceuticals
- KAI-4169
- KAI-9803
- Kalbitor
- Kalgene Pharmaceuticals
- KaloBios
- KalVista
- Kalydeco
- Kalypsys
- Kamada
- Kansas
- Kansas Bioscience Authority
- Kari Stefánsson
- Karl Ludwig Kley
- Karo Bio
- Karyopharm Therapeutics
- Kathleen Sereda Glaub
- Kathryn Biberstein
- Katrine Bosley
- KB2115
- Kedem Pharmaceuticals
- Keith Carter
- Keith Gottesdiener
- Keith Leonard
- Kelly Martin
- Kemin Pharma
- KemPharm
- Ken Bate
- Kendall Square
- Kendle International
- Kenneth Frazier
- Kenta Biotech
- Keppra
- Kereos
- Keryx Biopharmaceuticals
- Ketek
- Kevin Judice
- Kevin Sharer
- Kiadis Pharma
- kidney cancer
- kidney disease
- KIKA Clinical Solutions
- kinase
- Kinaxo
- Kineta
- Kinexus Bioinformatics
- King Pharmaceuticals
- Kingsbridge Capital
- Kiran Mazumdar
- Kiran Mazumdar-Shaw
- Kirsten Drejer
- Kissei Pharmaceutical
- Kite Pharma
- Kleanthis Xanthopoulos
- Kleiner Perkins Caufield & Byers
- Knome
- Knopp Neurosciences
- KNS-760704
- Kogenate
- Kohl
- Kolltan Pharmaceuticals
- Konrad Hochedlinger
- Koronis Pharmaceuticals
- Kos Parmaceuticals
- Kotinos Pharmaceuticals
- Kotra Pharma
- Kowa
- KRX-0401
- Krystexxa
- Kuvan
- KV Pharmaceutical
- Kymab
- Kynapid
- Kyowa Hakko
- Kyowa Hakko Kirin
- Kyphon
- Kythera Biopharmaceuticals
- L-dopa
- L. Patrick Gage
- LA BioMed
- La Jolla Pharmaceutical
- LabCorp
- Labopharm
- LabVantage
- Lacosamide
- Lambda Canada
- Langdon Miller
- Laninamivir
- Lannett
- lansoprazole
- laquinimod
- Larry Goldstein
- Lars Rebien Sørensen
- laster
- Latin America
- Latisse
- Laura Shawver
- Laurie Halloran
- laViv
- Lawrence Bloch
- Lawrence Tamarkin
- lawsuits
- layoffs
- LCZ696
- LEAD Therapeutics
- lebrikizumab
- Leerink Swann
- legislation
- Lehman Brothers
- Lemtrada
- Len Blavatnik
- Lentigen
- lenvatinib
- Leo Pharma
- Leslie Browne
- Letairis
- leukemia
- Leukemia & Lymphoma Society
- Lev Pharmaceuticals
- Levadex
- Levaquin
- Levemir
- Levitra
- levomilnacipran
- Lexapro
- Lexicon
- Lexicon Pharmaceuticals
- Lexiscan
- LFB Technologies
- LGD-4665
- LibiGel
- Licensing deals
- Life Science Pharmaceuticals
- life sciences
- Life Technologies
- LifeCycle Pharma
- Ligand Pharmaceuticals
- Light Sciences Oncology
- LigoCyte Pharmaceuticals
- Ligon Discovery
- Limerick BioPharma
- Linaclotide
- linagliptin
- LineaGen
- Linjeta
- Link Medicine
- Linkage Biosciences
- Lipid Sciences
- LipimetiX
- Lipitor
- liprotamase
- liquidation
- Liquidia Technologies
- Liraglutide
- Lisa Drakeman
- Lithium QD
- lithocholic acid
- Liver
- liver cancer
- Living Cell Technologies
- lixisenatide
- Lobbying
- Lodestone
- Lodotra
- Logical Therapeutics
- London Genetics
- Longevity
- Longwood Founders Fund
- Lonza Group
- Loramyc
- lorcaserin
- Lotus Tissue Repair
- Lou Gehrig's disease
- Lovenox
- Lpath
- LSP
- LTX-109
- LTX-315
- Lu AA21004
- Lucentis
- Lumavita
- Lumigan
- Luminex
- lumiracoxib
- Lumizyme
- Luna Innovations
- Lundbeck
- lung cancer
- Lunivia
- Lupin
- lupus
- Lupus Nephritis
- lurasidine
- lurasidone
- Lusedra
- Lux Biosciences
- Lux Research
- LX4211
- LX6171
- LXR-623
- LY156735
- LY2140023
- LY2189265
- Lycera
- lymphoma
- Lytix Biopharma
- MabCure
- MabThera
- macitentan
- MacroChem
- MacroGenics
- MacroGenitcs
- Macugen
- macular degeneration
- macular edema
- MAGE-A3
- major depressive disorder
- major market trends
- malaria
- Malaysia
- Malcolm Weir
- male contraceptive
- Malvinder Mohan Singh
- MammaPrint
- Manhattan Pharmaceuticals
- mannitol
- Mannkind
- manufacturing
- Manufacturing deal
- MAP Pharmaceuticals
- Mapatumumab
- Marburg Fever
- Marc Tessier-Lavigne
- Marcadia
- Marfan syndrome
- Margaret Hamburg
- Maria Crowe
- maribavir
- Marijn Dekkers
- Marina
- Marinus Pharmaceuticals
- Mario Capecchi
- marizomib
- Mark Goldsmith
- Mark Heesen
- Mark J. Fitzpatrick
- Mark Levin
- Mark McDade
- market access strategies
- MaRS Innovation
- Marshall Edwards
- Martin Evans
- Martin Mackay
- Martin Madaus
- Martin Mattingly
- Martin O'Malley
- Martin Simonetti
- Mary Lynne Hedley
- Maryland
- Mass Medical Angels
- Massachusetts
- Massachusetts Biologic Laboratory
- Massachusetts Biotechnology Council
- Massachusetts Building Trade Council
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- Massachusetts Life Sciences Center
- Matrix Laboratories
- Matrixx Initiatives
- Matt Emmens
- Matt Winkler
- Matthew Emmens
- Matthew Pfeffer
- Matuzumab
- Max Planck Society
- maximize
- Maxine Gowen
- Maxy-4
- MAXY-alpha
- MAXY-G34
- Maxygen
- Mayne Pharma
- Mayo Clinic
- Mayo Clinical Trial Services
- Mayrland Stem Cell Research Commission
- MBP8298
- MBX-2982
- McGill University
- McNeil
- MD Anderson
- MDMA
- MDRNA
- MDS
- MDS Analytical Technologies
- MDUFA
- MDV3100
- MDX-1100
- MDX-1106
- MDxHealth
- Meda
- Medarex
- Medgenics
- Medicago
- Medical device
- medical devices user fee agreement
- Medicare
- Medicines for Malaria Venture
- MediciNova
- Medicis
- Medicis Pharmaceutical
- Medicure
- Medidata Solutions
- Medigen
- MediGene
- Medimetriks Pharmaceuticals
- MedImmune
- MedImmune Ventures
- Mediomics
- MediQuest Therapeutics
- Meditrina
- Medivation
- Medivir
- MedNet Solutions
- Medtronic
- Melanoma
- melatonin
- Melinda Gates
- Melphalan
- MEM 3454
- Memorial Sloan-Kettering Cancer Center
- memory loss
- Memory Pharmaceuticals
- Menactra
- Menerba
- meningitis
- Menopause
- Menssana Research
- Menveo
- Mepact
- mepolizumab
- Merck
- Merck BioVentures
- Merck KgAA
- Merck Serono
- Mercury Therapeutics
- Merge Healthcare
- Mergers and Acquisitions
- Merial Animal Health
- Meritage Pharma
- Merlin Biosciences
- MerLion
- Merrimack Pharmaceuticals
- Merrion
- Mersana Therapeutics
- Merus
- Merz
- Mesafem
- Mesoblast
- MET inhibition
- Metabasis Therapeutics
- Metabolex
- Metabolic disorders
- Metabolic Solutions Development
- metabolics
- Metabolix
- Metabolon
- Metamark
- Metastasis
- Metastatix
- MethylGene
- MetMab
- Metozolv
- Mexico
- MF59
- MFAH
- MGCD0103
- MGI Pharma
- Micell Technologies
- Michael Budkie
- Michael J. Fox Foundation
- Michael Jaharis
- Michael Loberg
- Michelle Chang
- Michelson Diagnostics
- Michigan
- Michigan State University
- Microbia
- Microbix Biosystems
- MicroDose Therapeutx
- MicroIslet
- Micromet
- microplasmin
- microRNA
- microrobots
- Microsoft
- Midatech
- Middle East
- MiddleBrook Pharmaceuticals
- mifamurtide
- Migenix
- migraine
- Mikael Dolsten
- Mike Bonney
- Mike Leavitt
- Mike Varney
- Miles White
- milestones
- Millennium Pharmaceuticals
- Millipore
- Mind-NGR
- Mindray
- Minnesota
- minorities
- Minster Pharmaceuticals
- mipomersen
- Miragen Therapeutics
- Mircera
- Mirina Corporation
- miRNA
- Mirus
- Mission Therapeutics
- Missouri
- Mistral Pharma
- MIT
- Mitsubishi Tanabe Pharma
- MK-0524A
- MK-2206
- MK-4305
- MK-677
- MK-7009
- MM-398
- Moberg Derma
- Moffitt Cancer Center
- Mohr Davidow Ventures
- Molecular Biometrics
- molecular diagnostics
- molecular farming
- Molecular Insight Pharmaceuticals
- Molecular markers
- Molecular Partners
- Molecular Templates
- molecules
- Momenta Pharmaceuticals
- Moncef Slaoui
- monoclonal antibody
- MonoGen
- Monogram Biosciences
- MonoSol Rx
- Monovisc
- Monsanto
- Moraga
- MorphoSys
- Morphotek
- Morvus
- motavizumab
- motesanib
- Motivizumab
- Mount Sinai
- Mount Sinai School of Medicine
- Movetis
- Moxifloxacin
- Mozobil
- MP0112
- Mpex Pharmaceuticals
- MPM BioVentures
- MPM Capital
- MRC Technology
- MRSA
- MSI Methylation Sciences
- MSX-122
- mucal drug delivery system
- Multaq
- multi-specific therapeutic
- multikine
- multiple myeloma
- Multiple Myeloma Research Foundation
- multiple sclerosis
- Mundipharma
- Mundipharma International
- Muscular Dystrophy
- MVM Life Sciences Partners
- Myasthenia Gravis
- Myelodysplastic Syndromes
- myelofibrosis
- myeloma
- Mylan
- Mylan Laboratories
- Mylan Pharmaceuticals
- Mylotarg
- Mymetics
- myocardial infarction
- Myogen
- Myotec Therapeutics
- Myozyme
- Myriad Genetics
- Myriad Pharmaceuticals
- Nabi Biopharmaceuticals
- Nabriva Therapeutics
- NABsys
- Nancy Wexler
- nano-biopolymers
- Nanobac Pharmaceuticals
- NanoBio Corp.
- Nanobody
- Nanogen
- NanoInk
- Nanologica
- nanomedicine
- nanoparticles
- Nanosphere
- NanoString Technologies
- nanotechnology
- NanoTherapies
- nanotube
- NanoViricides
- naproxcinod
- naproxen
- nasal spray
- Nastech
- Nat Ricciardi
- Natco Pharma
- National Cancer Institute
- National Institutes of Health
- National Physical Laboratory
- natrecor
- Naturlose
- Naurex
- Nautic Partners
- Nautilus Neurosciences
- Navigenics
- NCATS
- NCPharma
- NCX 116
- NDM-1
- Nebido
- Needle Insertion
- needle-free drug delivery systems
- Neil Gibson
- Nektar Therapeutics
- NeoGenomics
- neonatal
- Neopharm
- neoprobe
- Neose Technologies
- Neostem
- Neovacs
- Nephron Pharmaceuticals
- nephropathy
- Neratinib
- Nereus Pharmaceuticals
- nerve damage
- Nerviano
- Nestle
- Neuera Pharmaceuticals
- Neumune
- Neupogen
- Neupro
- Neuradiab
- Neuralgia
- Neuralstem
- Neuraltus Pharmaceuticals
- NeurAxon
- Neurim
- Neurimmune
- Neuro-Hitech
- Neuro3d
- Neurobiological Technologies
- neurobiology
- Neurochem
- neurocrine biosciences
- neuroendocrine
- Neurogen
- NeurogesX
- Neurologix
- Neuromed
- neuropathic pain
- NeuroPhage Pharmaceuticals
- Neuropharm
- Neuroptix
- neuroscience
- NeuroScience Pharmaceuticals
- neuroscience research
- NeuroSearch
- NeuroSigma
- Neurotech
- Neurotherapeutics Pharma
- NeuroVax
- Neuvenge
- New American Therapeutics
- new blood
- New Drug Application
- New Drugs
- New England Journal of Medicine
- New Enterprise Associates
- New Jersey
- New Leaf Venture Partners
- New Molecular Entity
- New York
- NewBridge Pharmaceuticals
- NewLink Genetics
- Newron
- Newron Pharmaceuticals
- newsday
- Nexavar
- NexBio
- Nexium
- NexMed
- NextBio
- nexterone
- NextGen Sciences
- Nextrials
- NextWave Pharmaceuticals
- neXus therapeutics
- NGM Biopharmaceuticals
- NGX-1998
- NGX-4010
- NGX267
- NGX426
- NI-0401
- NI-0501
- Niacin
- NIC002
- NIC5-15
- NICE
- Nicholas Piramal
- Nicholas Stergis
- Nick Seay
- NiCox
- NicVAX
- Niemann-Pick type C disease
- NIH
- Nile Therapeutics
- Nimbus
- nimotuzumab
- NinePoint Medical
- Nintex
- Nissan Chemical Industries
- Nitec Pharma
- nitric oxide
- Nitromed
- Nivestim
- NixOx
- NKT Therapeutics
- NKTR-102
- NLX-P101
- NM100060
- NME approvals
- NMED-1077
- nNOS inhibitor
- Nobel Prize
- Nobelpharma
- Nobilon
- Nodality
- Noel Doheny
- Nomad Bioscience
- non-Hodgkin's lymphoma
- non-small cell lung cancer
- Nonprofit
- Nordic Bioscience
- NormOxys
- North Carolina
- North Shore Life Sciences Accelerator
- Northfield Laboratories
- Northstar Neuroscience
- Northwest Biotherapeutics
- Northwestern University
- Northwick Park
- Norway
- Norwich Pharmaceuticals
- nose to brain
- Nostrum Pharmaceuticals
- NOV-002
- NovaBay Pharmaceuticals
- Novacea
- Novacta Biosystems
- NovaDel
- Novagali
- Novalar Pharmaceuticals
- NovaMed
- NovaQuest
- Novartis
- Novartis Venture Fund
- Novavax
- Novella Clinical
- Novelos
- Noven Pharmaceuticals
- Novexel
- NovImmune
- Novo Nordisk
- Novocell
- Novogen
- NovoSeven
- Novosom
- Novozymes
- Noxxon pharma
- NPL-2008
- Nplate
- NPS Pharmaceuticals
- NPSP558
- NTC-801
- NUCRYST Pharmaceuticals
- Numerate
- Nuon Therapeutics
- Nupathe
- Nuren Pharmaceuticals
- Nuron
- Nutra Pharm
- Nuvelo
- Nuvigil
- Nuvion
- Nuvo
- Nuvo Research
- NV1FGF
- NVA237
- NVC-422
- NVCA
- Nventa
- NVIDIA
- NX-1207
- NXL103
- NXL104
- NXN-188
- Nycomed
- Nymox
- NYUCI
- Obama Administration
- obatoclax
- obesity
- obsessive-compulsive disorder
- OccuLogix
- Oceana Therapeutics
- Ocera Therapeutics
- Ockham
- ocrelizumab
- ocriplasmin
- OctoPlus
- ocular diseases
- Ocular Therapeutix
- Oculus Innovative Sciences
- Odanacatib
- oesteoporosis
- ofatumumab
- offshore outsourcing
- Ofirmev
- oglemilast
- OGX-011
- Ohio State University
- Okarios
- olaparib
- Oligomerix
- Oliver Smithies
- Olympus Life Sciences
- Omacetaxine
- omacetaxine mepesuccinate
- omecamtiv mecarbil
- Omeros
- Omicia
- Omid Farokhzad
- Omigard
- Omni International
- Omnicare Clinical Research
- OmniComm
- Omnitura Therapeutics
- OMP- 21M18
- OMP-18R5
- Omrix Biopharmaceuticals
- OMS103HP
- Omthera Pharmaceuticals
- On the Radar
- Onbrez Breezhaler
- Oncalis
- Oncobiologics
- Oncoceutics
- OncoGenex
- Oncolin Therapeutics
- Oncology
- Oncolys BioPharma
- Oncolytics
- OncoMed Pharmaceuticals
- OncoMethylome
- Onconova Therapeutics
- Oncophage
- Oncoscience
- Oncothyreon
- OncoVex
- OncoVista Innovative Therapies
- Onexa
- Onglyza
- Ono Pharmaceutical
- onrigin
- Ontaril
- Ontario
- Onyx Pharmaceuticals
- Opana
- Opaxio
- Open source R&D
- OpenClinica
- operations suspension
- Opexa
- OpGen
- ophthalmic
- ophthalmology
- Ophthotech
- Opioid Analgestic
- opioid dependence
- opioid-induced bowel dysfunction
- opioids
- Opko
- OpRA III
- Opsona Therapeutics
- OPT-80
- Optherion
- optimal pricing
- Optimata
- Optimer Pharmaceuticals
- OptiNose
- Oracea
- Oracle
- Oragenics
- oral drug delivery platform
- oral formulation
- oral spray formulation
- Oral-lyn
- Oralair
- orally disentegrating tablet
- Oramed
- Oramed Pharmaeuticals
- Orasi Medical
- Oraya Therapeutics
- orBec
- OrbiMed Advisors
- Orchestra Therapeutics
- Orchid Cellmark
- Orchid Chemicals
- Oregon Health & Science University Knight Cancer Institute
- Orexigen Therapeutics
- Orexin
- Orexo
- Organogenesis
- Organon
- Origen Therapeutics
- OriGene Technologies
- Origenis
- Orion
- Oritavancin
- orlistat
- ormosil
- orphan drug status
- Orphan Europe
- Orphan Status
- Orphazyme
- Ortho Biotech
- Ortho-McNeil
- Orthos Europe
- Osage University Partners
- Osage Unversity Partners
- Oscient Pharmaceuticals
- OSI Pharmaceuticals
- Osiris Therapeutics
- Osmotica
- Osprey Pharmaceuticals
- Ostarine
- osteoarthritis
- Osteologix
- osteoporosis
- otamixaba
- OTC drugs
- Otelixizumab
- Otologic
- Otonomy
- Otsuka
- Otsuka Pharmaceuticals
- outbreak
- outsourcing
- Outsourcing Deals
- OvaGene Oncology
- ovarian cancer
- Ovation Pharmaceuticals
- overactive bladder
- overseas clinical trials
- OX1
- OX914
- Oxagen Limited
- Oxford BioMedica
- Oxford Bioscience Partners
- Oxford Biotherapeutics
- Oxford Gene Technology
- Oxford Immunotec
- Oxford Nanopore
- Oxford University
- OXiGENE
- Oxo International
- OXY11A
- Oxycontin
- Oxycyte
- Oxygen Biotherapeutics
- Oxyrane
- oxyrens
- Oxytrol
- ozarelix
- p53 biomarker
- Pacgen Biopharmaceuticals
- Pacific Biomarkers
- Pacific Biosciences
- Pacira Pharmaceuticals
- Paclitaxel
- pagoclone
- Pain Therapeutics
- pain therapy
- painkiller
- Paion
- Paladin Labs
- Palatin Technologies
- Palladia
- Palo Alto
- Panacea Biotec
- Panacos
- Pancreate
- pancreatic cancer
- pandemic
- pandemic flu
- Pandemic Influenza
- PanGenetics
- Panmira
- Panomics
- PanOptica
- Paoin
- Paolo Paoletti
- Par Pharmaceutical
- Paragon Biomedical
- Paragon Bioservices
- Paratek Pharmaceuticals
- parathyroid hormone
- Parexel
- Parion Sciences
- Parkinson's
- Parkinsons Drug
- PARP inhibitor
- Part one of our three part series
- partnership
- Partnerships CROs
- Pascal Soriot
- patent
- patent application
- patent approval
- Patent challenge
- patent expiration
- Patent infringement
- patent lawsuit
- Patent news
- patent rules
- patents
- Patheon
- Pathway Therapeutics
- patient recruitment
- PatientKeeper
- PatientsLikeMe
- Patrick Mahaffy
- Patrick Vallance
- Patrik De Haes
- Paul Bisaro
- Paul Capital Healthcare
- Paul Desjourdy
- Paul Greengard
- Paul Herrling
- Paul Maeder
- Paul Rubin
- Paul Touhey
- pazopanib
- PBMs
- PCI-32765
- PCK3145
- PDI
- PDL BioPharma
- PDL241
- PDS Biotechnology
- PDUFA
- Pearl Therapeutics
- PecFent
- Pediapharm
- pediatric drug development
- Pegasus Biologics
- Pegasys
- Pegasystems
- Pegintron
- Peking University
- Peloton Therapeutics
- Pelotonia
- Penn State
- Pennsaid
- Pennsylvania
- PentaStaph
- Penwest Pharmaceuticals
- Peplin
- peptide
- peptides
- Peptimmune
- Peramivir
- Perampanel
- Perceptive Informatics
- Percivia
- Peregrine
- Perifosine
- Perkinelmer
- Perlegen
- Perlegen Sciences
- Perrigo
- Perseus-Soros Biopharmaceutical Fund
- Persistent Systems
- personalized medicine
- pertuzumab
- Pervasis Therapeutics
- Peter Fellner
- Peter Hirth
- Peter Kiener
- Peter Kim
- Peter M. Hecht
- Peter Meldrum
- Peter Mueller
- Pevion Biotech
- PF-03187207
- PF-299
- Pfenex
- Pfizer
- Pfizer Global Research
- Pfizer Ventures
- PG110
- Pharma Genexx
- Pharma news
- Pharmacells
- pharmaceutical companies
- pharmaceutical company
- pharmaceutical industry
- pharmaceutical outsourcing
- pharmaceuticals
- Pharmacopeia
- pharmacovigilance
- Pharmacyclics
- PharmaEngine
- PharmaGap
- Pharmalink AB
- PharmaNet
- PharmaNet Development Group
- PharmaPros
- Pharmaron
- Pharmascience
- Pharmasset
- Pharmatech
- Pharmatech Oncology
- Pharmathene
- PharmaVigilant
- Pharmaxis
- PharmEng
- Pharmexa
- Pharming
- Pharmion
- Pharmos
- Pharnext
- Pharsight
- Phase 2 Discovery
- Phase Forward
- Phase I
- Phase II
- Phase III
- Phase IV
- PhaseBio Pharmaceuticals
- Phenex
- Phenomix Corporation
- phenoxodiol
- Philanthropy
- Philip Astley-Sparke
- Phillipe Archinard
- Philogen
- Phlexglobal
- Phoenix
- PhRMA
- PHT
- PHX1149
- Phylogica
- physicians
- Phytopharm
- PI-88
- PI3-K
- Picoplatin
- Piedmont Pharmaceuticals
- Pieris
- Pierre Fabre Medicament
- Pilgrim Software
- Pill-Plus
- pimavanserin
- Pioneer
- pipeline
- Pipex
- Pique Therapeutics
- Piramed
- Pirbright
- pirfenidone
- Pistoia Alliance
- Pittsburgh Center for Vaccine Research
- Pittsburgh Life Sciences Greenhouse
- Pivotal BioSciences
- Pixantrone
- PixelEXX Systems
- Pixuvri
- PL-100
- placebo effect
- Plan B
- Plasticell
- Plavix
- Plethora Solutions
- Plexxikon
- Plicera
- plinabulin
- Pliva
- Pluristem Technology
- PLX-PAD
- PLX4032
- PMA
- PML
- PN 400
- PN2034
- PN400
- Point Biomedical
- Point Therapeutics
- PointCross Life Sciences
- Polaris Venture Partners
- poloxamer 188
- polyheme
- PolyMedix
- polymer
- Polymer Technology Group
- Polyphor
- PolyTherics
- ponatinib
- Poniard
- Poniard Pharmaceuticals
- Portola Pharmaceuticals
- Posidur
- Postherpetic Neuralgia
- POT-4
- Potelligent Technology
- Potentia Pharmaceuticals
- Poxel
- Pozen
- PPD
- PR0015
- PRA International
- Pradaxa
- pralatrexate
- pramiconazole
- Prana
- prasugrel
- Precedex
- Precision Therapeutics
- preclinical
- Precyse Solutions
- Predictive Biosciences
- pregabalin
- PregLem
- PreMD
- Presidio Pharmaceuticals
- Pressure BioSciences
- Prestwick Pharmaceuticals
- Prevacid
- Prevalere
- Prevnar
- Prevnar 13
- Prexige
- Prezista
- PricewaterhouseCoopers
- pricing
- Primary Immune Deficiencies
- Primera Biosystems
- priority
- Prism Pharmaceuticals
- Pristiq
- Private Equity
- private placement
- Privigen
- PRM-151
- PRO 2000
- Pro Bono Bio
- Pro-Pharmaceuticals
- Proaegis Biosciences
- Probiodrug
- Probuphine
- Proceedings of the National Academy of Sciences
- Prochieve
- Prochymal
- Procter & Gamble
- product portfolio
- proellex
- Profectus BioSciences
- Profex
- ProFibrix
- Profil Institute
- profits
- Progen Pharmaceuticals
- Progenics Pharmaceuticals
- Progenitor Labs
- Prograf
- Project BioShield
- Project Boss
- Prolensa
- Prolexys Pharmaceuticals
- Prolia
- Prolias
- Prolong Pharmaceuticals
- Promacta
- Promedior
- Prometheus Laboratories
- ProMetic Life Sciences
- Promosome
- Pronota
- ProSanos
- ProSavin
- Prosensa
- Prosonix
- Prospect Venture Partners
- Prostate Biomarkers
- Prostate Cancer
- ProStrakan
- Prostvac
- ProtAffin
- Protagen
- Protagonist Therapeutics
- Protalix
- Protectan
- protein
- Protein Sciences
- Proteo Biotech
- Proteolix
- Proteome Systems
- proteomics
- Proteomics International
- Proteon Therapeutics
- Proteostasis
- ProteoStasis Therapeutics
- Proteros biostructures
- Proteus Biomedical
- Protez Pharmaceuticals
- Protherics
- Protiva
- Protonix
- Protox Therapeutics
- Provectus Pharmaceuticals
- Provenge
- Provigil
- Proximagen Neuroscience
- PRT-201
- Prulifloxacin
- PRX302
- PS433540
- PSI-7977
- PSI-938
- psilocybin
- PsiOxus Therapeutics
- pSivida
- psoriasis
- Psyadon Pharmaceuticals
- PT003
- PTC Therapeutics
- PTC124
- PTI-721
- PTK 0796
- PTSD
- public offering
- public trust
- Pulmatrix
- pulmonary arterial hypertension
- Pulmonary Disease
- Puma Biotechnology
- PuraMed BioScience
- Purdue Pharma
- Purdue University
- PURE Bioscience
- PureTech Ventures
- PX-478
- PX-866
- Pyramax
- PZ-601
- Q Chip
- Q Therapeutics
- Q&A
- Q-Med
- QAB140
- QAB149
- Qiagen
- Qlaira
- QLT
- Qnexa
- QR Pharma
- QRxPharma
- Quad
- Quaker Bioventures
- QualiMed
- Qualitest
- QuantaLife
- Quanterix
- Quanticel Pharmaceuticals
- Quantros
- Quarfloxin
- Quark Pharmaceuticals
- QuatRx Pharmaceuticals
- Quebec
- Queen Mary
- Queen's University
- Quest Diagnostics
- Questcor
- Quintiles
- QureInvest
- Qutenza
- QVA149
- Qwell Pharmaceuticals
- R&D
- R&D budget
- R&D spending
- R343
- R7025
- R788
- Rachel King
- RAD001
- radezolid
- radiation
- Radiation Therapy Oncology Group
- Radius Health
- Radius Ventures
- RainDance Technologies
- Raloxifene
- Ralph Steinman
- Ramius
- Ranbaxy
- Randal Kirk
- Rapaflo
- Raptiva
- Raptor Pharmaceutical
- RaQualia
- rare diseases
- Rasilez
- Rasitrio
- Ratiopharm
- Raven Biotechnologies
- raxibacumab
- Raymond Warrell
- Raymond Woosley
- Razadyne
- RDEA594
- ReachBio
- Reagan-Udall Foundation
- Reata
- Reata Pharmaceuticals
- Rebamipide
- Rebetol
- Rebif
- recall
- Recentin
- ReceptoPharm
- Receptor BioLogix
- Receptos
- Recession
- Reckitt Benckiser
- Reclast
- Recordati
- Red Cross
- RedOak Logic
- Redpoint Bio
- Regado Biosciences
- regeneration
- regenerative medicine
- Regeneron
- Regeneron Pharmaceuticals
- RegeneRx
- Regenesis
- regorafenib
- Regulation
- Regulators
- regulatory affairs
- regulatory approvals
- Regulus Therapeutics
- REIMBURSEMENT
- reimportation
- Relapse
- Relational Investors
- release formulation
- relenza
- ReliaGene
- Reliant Pharmaceuticals
- Relistor
- Relovair
- Reloxin
- Relsys International
- Relypsa
- Rember
- Remicade
- Remodulin
- Remoxy
- Rempex
- Remune
- Remura
- ReN001
- Renagel
- renal cell carcinoma
- ReNeuron
- Renovis
- Renovo
- Rensselaer Polytechnic Institute
- Replidyne
- Repligen
- Repros
- Republicans
- Research Network
- ReSearch Pharmaceutical Services
- ResearchMoz
- Resignation
- Resolve Therapeutics
- Resolvyx Pharmaceuticals
- Respira Therapeutics
- respiratory diseases
- RespiVert
- Response
- Response Genetics
- Restless Legs Syndrome
- Restructure
- restructuring
- resveratrol
- Resverlogix
- Retaane
- Retacrit
- Retavase
- retention bonus
- retigabine
- retinal vein occlusion
- retinopathy
- reumatoid arthritis
- REVA Medical
- Revance Therapeutics
- Revascor
- reverse merger
- Revimmune
- Revlimid
- Revotar Biopharmaceuticals
- Rexahn Pharmaceuticals
- Rexin-G
- Reyataz
- Rezonic
- RG7204
- RGH-188
- RGN-259
- RHEI Pharmaceuticals
- Rheoscience
- Rheumatoid Arthritis
- rheumatology
- rhFIB
- Rhode Island
- Rhucin
- RhuDex
- rHuPH20
- Rhythm Pharma
- Riastap
- Rib-X Pharmaceuticals
- Ricerca Biosciences
- Richard A. Gonzalez
- Richard Garr
- Richard Gold
- Richard Gonzalez
- Richard Hollis
- Richard Jones
- Richard Klein
- Richard Pops
- Richard Scheller
- Richard Selden
- Richter-Helm BioLogics
- Rick Winningham
- ridaforolimus
- Ridge Diagnostics
- rifaximin
- Rigel Pharmaceuticals
- Rinat Neuroscience
- Riquent
- RISPERDAL
- Ritalin
- Ritonavir
- Rituxan
- rituximab
- rivaroxaban
- RLIP76
- RNA
- RNAi
- RoActemra
- Robert A. Bradway
- Robert Bradway
- Robert Califf
- Robert Coughlin
- Robert Coury
- Robert Langer
- Robert Sobol
- Robert Yates
- Roch Doliveux
- Roche
- Roche Venture Fund
- Rock Spring Ventures
- Rockefeller University
- Rockwell Medical
- Roger Newton
- Roger Tung
- Rogosin Institute
- Roka Bioscience
- rolofylline
- Romiplostim
- Ron Cohen
- Ronacalaret
- Ronald Berninger
- Rosa
- Rosetta Genomics
- rotateq
- ROVI
- Royal DSM
- royalty payments
- RP101
- RP103
- RRD International
- RT002
- RTA 402
- RTI Biologics
- RusNano
- Russell Greig
- Russell Herndon
- Russell Medford
- Russia
- Rutgers University
- ruxolitinib
- RVX-208
- RXi Pharmaceuticals
- S Aureus
- s sales
- S*BIO
- Sabril
- SAC Capital Advisors
- SAFE-BioPharma
- safety data
- safety profile
- safinamide
- Sage Bionetworks
- Sage Therapeutics
- Sagent Pharmaceuticals
- Saladax Biomedical
- salary reduction
- sale
- sales and marketing
- Salix Pharmaceuticals
- salsalate
- Sam Waksal
- SAM-101
- Samaritan Pharmaceuticals
- Samsung
- Samuel Saks
- San Diego
- San Francisco
- San Francisco Chronicle
- Sancuso
- Sanderling Ventures
- Sandoz
- SANE Vax
- Sanford C. Bernstein
- Sangamo BioSciences
- Sangart
- Sanjay Kaul
- Sanofi
- Sanofi Pasteur
- Santaris Pharma
- Santarus
- Santen Pharmaceutical
- Santhera
- SantoSolve
- Sapacitabine
- Sapheon
- Saphris
- Sapiens
- SARcode Bioscience
- Sareum
- sarilumab
- SARmont
- Sars
- Sartor
- Sartorius Stedim
- SAS
- Sativex
- Satori Pharmaceuticals
- satraplatin
- SATURN study
- Savara Pharmaceuticals
- savella
- Savient Pharmaceuticals
- saxagliptin
- SB-509
- SB1317
- SB1518
- SB1578
- SB939
- sBLA
- SC4SM
- scarring
- ScenPro
- Schering-Plough
- schizophrenia
- schizophrenia drug
- Schrodinger
- Schwabe Pharmaceuticals
- Schwarz BioSciences
- Schwarz Pharma
- SciClone
- Sciele Pharma
- science
- Scientia Advisors
- SciFluor
- Scil Proteins
- Scil Technology
- Scleroderma
- sclerosis drug
- SCOLR Pharma
- ScoreAHit
- scorpion bites
- Scotland
- Scott Brown
- Scott Harkonen
- Scripps Research Institute
- Seahorse Bioscience
- Sean Harper
- Seaside Therapeutics
- Seattle
- Seattle Genetics
- Seattle Times
- SEC
- Second Genome
- second half
- Second Quarter
- seizures
- SEL-068
- Selecta Biosciences
- selumetinib
- Selzentry
- semagacestat
- SemBioSys
- SemBioSys Genetics
- Seminar
- Semprus Biosciences
- Sempurs Biosciences
- Senesco Technologies
- senicapoc
- SensiGen
- Sensipar
- SEP-225289
- Sepracor
- sepsis
- Sequel Pharmaceuticals
- Sequella
- sequencing
- Sequenom
- SER-3
- Serada
- Serdolect
- Serentis
- Serenx
- Serevent
- series c
- Sermo
- Sernova
- Serono
- Seroquel
- Servier
- setrobuvir
- Severin Schwan
- SF-1019
- SFJ Pharmaceuticals
- SGN-35
- SGN-40
- SGX pharmaceuticals
- Shantha Biotech
- Shareholder Activists
- shareholder lawsuits
- shareholders
- Sharklet Technologies
- Shenzhen Neptunus
- Sheri McCoy
- Shield Therapeutics
- Shin Poong Pharmaceutical
- shingles
- Shionogi
- Shire
- Shire Pharmaceuticals
- shistosoma haematobium
- sickle cell
- Sidney Taurel
- Sierra Neuropharmaceuticals
- Siga Technologies
- Sigma Pharmaceuticals
- Sigma-Aldrich
- Sigma-Tau
- Signum Biosciences
- Sijmen de Vries
- Silence Therapeutics
- Silenor
- silk-based microneedle system
- silver
- Simbionix
- Simcere
- Simcyp
- Simponi
- Simulations Plus
- simvastatin
- Sinclair Pharma
- Singapore
- Singulair
- Singulex
- SingVax
- Sinobiomed
- Sinovac Beijing
- Sinovac Biotech
- Sir Andrew Dillon
- Sir Christopher Evans
- Sirion Therapeutics
- Siritis Pharmaceuticals
- Sirius Genomics
- siRNA
- Sirna Therapeutics
- Sirtris Pharmaceuticals
- Skelaxin
- skin cancer
- skin infections
- Sky One Medical
- SkyePharma
- Skyscape
- SL-701
- Slate Pharmaceuticals
- small business
- Small Business Innovation Research
- small molecules
- Smallpox
- SmartCells
- smell
- smoking cessation
- Snowdon
- SNS-595
- Social Media
- sofinnova ventures
- Sol Barer
- Solabegron
- Solace Pharmaceuticals
- solaneuzumab
- solanezumab
- Solazyme
- Soligenix
- Soliris
- Solodyn
- Solpura
- Soltex Consulting
- Soluble Therapeutics
- Solvay Pharmaceuticals
- Solzira
- SOMA
- Somatuline
- Somaxon
- Somnus Therapeutics
- Sonexa Therapeutics
- Sonus Pharmaceuticals
- Sopherion Therapeutics
- Sorbent Therapeutics
- Sosei
- South Africa
- South Carolina
- South San Francisco
- SP-6300
- Spain
- Sparta Systems Partners
- SparVax
- Spaulding Clinical
- Specialized Therapeutics
- specialty drugs
- Spectrum Pharmaceuticals
- Speedel
- Spencer Pharmaceutical
- SpePharm Holding
- Spheramine
- Spherix
- spin-off
- Spinal Concepts
- spinal muscular atrophy
- Spinal Muscular Atrophy Foundation
- Spine Wave
- Spinifex
- spray dried dispersion technology
- Spring Bank
- SpringLeaf Therapeutics
- spur
- SR One
- SRT-1720
- SSRI
- St. Jude Medical
- St. Louis
- STA-4783
- STA-9090
- Stabilitech
- Stallergenes
- Stanford University
- Stanley Erck
- Staph Leavenworth Bakali
- Starpharma
- Start Licensing
- start-up
- Stason Pharmaceuticals
- statins
- Stedesa
- Stedivaze
- stem cell
- Stem cell research
- Stem Cell Sciences
- Stem Cell Therapeutics
- Stem cells
- StemCells Inc.
- Stemedica
- Stemgent
- Stemline Therapeutics
- Stempeutics
- stents
- Stephen Ferruolo
- Stephen Seiler
- Stephen Simes
- Stephen Spielberg
- Steve Hartig
- Steve Jobs
- Steve Kaldor
- Steve Reed
- Steve Worland
- Steven Burrill
- Steven Engle
- Steven F. Goldstone
- Steven Holtzman
- Steven Kriegsman
- Steven Quay
- Stiefel Laboratories
- Stimuvax
- strain
- strategy
- Strativa Pharmaceuticals
- Strattera
- stroke
- Stromedix
- Stuart Peltz
- STX-100
- subcutaneous
- sublinqual
- Sucampo
- sugammadex
- Sumavel
- Summit Corporation
- Sun Pharmaceuticals
- Sunesis Pharmaceuticals
- Suntron
- superDimension
- SuperGen
- Supernus
- SuppreMol
- Supreme Court
- Surface Logix
- Surfaxin
- SurgiVision
- SurModics
- Susan Desmond-Hellman
- Susan Desmond-Hellmann
- Susan Molineaux
- Sutent
- Sutro Biopharma
- Suvorexant
- Suzy Jones
- SV Life Sciences Advisers
- Sweden
- Swedish Orphan
- Swedish Orphan Biovitrum
- swine flu
- Swiss Pharma Contract
- Switzerland
- Sygnis Pharma
- Symbicort
- SymBio Pharmaceuticals
- Symbollon
- Symphogen
- Symphony GenIsis
- Symyx Technologies
- Synageva BioPharma
- Synarc
- Synavive
- Syncria
- Syngene
- Syngenta
- Synosia Therapeutics
- Synta Pharmaceuticals
- Syntaxin
- Synthetic biology
- synthetic vaccine
- SynthRx
- Synvisc-One
- Synvista Therapeutics
- Syracuse University
- Systems Medicine
- T
- T Cells
- T-cell
- T-cells
- T-DM1
- T2 Biosystems
- Tabex
- Tachi Yamada
- TachoSil
- Tadalafil
- Tafamidis
- TaiGen Biotechnology
- Taiho Pharmaceutical
- Taijitu Biologics
- Taiwan
- TAK-390MR
- TAK-475
- Takeda
- Talabostat
- Talecris Biotherapeutics
- Taligen
- Taligen Therapeutics
- taliglucerase alfa
- Tamibarotene
- Tamiflu
- Tamir Biotech
- Tandem Diabetes Care
- tanezumab
- Tanox
- tapentadol
- TapImmune
- taranabant
- Tarceva
- Targacept
- Targanta Therapeutics
- TargeGen
- Targeted Genetics
- Targeted Molecular Diagnostics
- targeted therapies
- Taribavirin
- Taris Biomedical
- Tarix
- Taro Pharmaceuticals
- Tarsa Therapeutics
- Tasigna
- tasimelteon
- tasocitinib
- taspoglutide
- tau oligomers
- TauRx Therapeutics
- TauTaTis
- Taxotere
- Taxus
- TB-403
- TC-2696
- TC-5214
- TC-5619
- TC-6499
- TCN E-Systems
- Tecarfarin
- technology
- Technosphere
- Technosphere Insulin
- tedizolid
- Teijin Pharma
- Teikoku Pharma
- Teklamo
- Tekmira
- Tekturna
- Tel Aviv University
- telaprevir
- telatinib
- Telavancin
- telcagepant
- Telik
- Telormedix
- Tempero Pharmaceuticals
- tender offer
- Tengion
- Tensha Therapeutics
- teplizumab
- Terapio
- Tercica
- teriflunomide
- Terry Hisey
- Terry McGuire
- tesamorelin
- Tesaro
- Tesetaxel
- tesofensine
- Tethys Bioscience
- TetraLogic
- Tetraphase Pharmaceuticals
- Teva Parental Medicines
- Teva Pharmaceutical Industries
- Texas
- Texas A&M
- tezampanel
- TG4010
- tgAAC94
- Thallion Pharmaceuticals
- The Bill & Melinda Gates Foundation
- The Jackson Laboratory
- The Medicines Company
- The University of Texas at Austin
- Thelin
- Theraclone Sciences
- Therapeutic Discovery Credit
- Therasis
- Theratechnologies
- Theravance
- TheraVida
- Therion Biologics
- Thermo Fisher
- ThermoGenesis
- Theron Odlaug
- Thiakis
- Third Point
- Third Rock Ventures
- Third Round
- Thomas A. Waltz
- Thomas Bigger
- Thomas Finneran
- Thomas Harlan
- Thomas J. Spencer
- Thomas Struengmann
- Thomson Reuters
- Three Rivers
- Threshold Pharmaceuticals
- Thrombin
- thrombocytopenia
- ThromboGenics
- Thrombosis
- thymalfasin
- Tibotec
- ticagrelor
- TiGenix
- Tigris Pharmaceutical
- Tikvah Therapeutics
- Tim Anderson
- Tim Noyes
- Timothy C. Rodell
- Tina Nova
- Tioga Pharmaceuticals
- TIPO-1
- tissue engineering
- Titan Pharmaceuticals
- tivozanib
- TKS1225
- TL011
- TLN-232
- TMC435
- TNFerade
- to-BBB
- Tobacco
- Tocosol Paclitaxel
- Tocris
- tofacitinib
- TOK-001
- Tokai Pharmaceuticals
- Tolera Therapeutics
- Tolerx
- Toll-like receptors
- Tolmar Holdings
- Tom Watkins
- tonabersat
- Tony West
- Top 5
- Topaz Pharmaceuticals
- Topica Pharmaceuticals
- Topigen Pharmaceuticals
- Topiramate
- Topogen
- Torcetrapib
- toremifene
- Torisel
- TorreyPines Therapeutics
- Tovaxin
- Toviaz
- Tracking Stocks
- Tracleer
- Tracy Deisher
- Traditional medicine
- Tragara Pharmaceuticals
- Tramadol
- Transave
- Transcend Medical
- Transcept Pharmaceuticals
- Transdel
- transdermal drug delivery
- Transgene
- Transgeneron Therapeutics
- Transgenics
- Transition Therapeutics
- Transkaryotic Therapies
- Translational Genomics Research Institute
- translational research
- TransMolecular
- transparency
- TransPharma
- TransTech
- TransVax
- Tranzyme Pharma
- Trastuzumab-DM1
- Trasylol
- Tredaptive
- Trellis Biosciences
- tremelimumab
- trends
- Trevena
- Trevor Mundel
- trial safety
- Trident Biotech
- Trilipix
- Trimel Pharmaceuticals
- Trimeris
- Trinity College Dublin
- Trinity Pharma Solutions
- Triolex
- Tripos
- Tris Pharma
- Trisomy 21
- Trius Therapeutics
- Trizytek
- Trophos
- TroVax
- Troy Wilson
- TRU-015
- TRU-016
- Trubion Pharmaceuticals
- TTP399
- Tuberculosis
- Tufts Center for Drug Development
- Tufts University
- Tufts University School of Engineering
- tumors
- twitt
- Tygacil
- Tykerb
- Type 1 Diabetes
- Type 2 Diabetes
- Type I diabetes
- Tyrian Diagnostics
- Tysabri
- Tyvaso
- TZP-101
- U.S. Oncology
- U3
- UBC Group
- UC Davis
- UC Davis Health System
- UC Irvine
- UCB
- UCSB
- UCSD
- UCSF
- UK
- UK Stem Cell Bank
- ulcerative colitis
- ulipristal
- Uloric
- Ultragenyx
- UNC
- undefined
- Undruggable targets
- Unigene Laboratories
- Unilife
- unions
- Unit Dose Budesonide
- United Arab Emirates
- United Kingdom
- United States
- United Therapeutics
- Univerfsity of Pittsburgh School of Medicine
- Universal vaccine
- University at Buffalo
- University College of London
- University deal
- University of Alabama
- University of Arizona
- University of Colorado
- University of Illinois
- University of Kentucky
- University of Leeds
- University of London
- University of Manchester
- University of Miami
- University of Michigan
- University of Pennsylvania
- University of Pittsburgh
- University of Rhode Island's College of Pharmacy
- University of Tennessee
- University of Texas
- University of Utah
- University of Virginia
- University of Warwick
- university research
- upfront payment
- Uplyso
- Upsher-Smith Laboratories
- Upstate Pharma
- urinary incontinence
- Urocidin
- Ursodiol
- USC
- USCF
- USDA
- USDA Western Regional Cancer Center
- ustekinumab
- UTRF
- V-Clip Pharmaceuticals
- V3381
- V710
- VA111913
- Vacc-4x
- Vaccines
- Vaccines Technologies
- Vaccinogen
- vaginal gel
- Valcyte
- Valeant Pharmaceuticals
- ValenTx
- Valeritas
- Valocor Therapeutics
- Valstar
- Valtropin
- Van Andel Research Institute
- Vancomycin
- Vanda Pharmaceuticals
- Vanderbilt
- vandetanib
- Vantia Therapeutics
- Varian
- Vasogen
- Vasovist
- Vatican
- Vaxart
- VaxDesign
- Vaxfectin
- Vaxgen
- Vaximm
- VaxInnate
- VBI
- VC
- VC / M&A
- Vectibix
- Vectura Group
- Veeva Systems
- Vegf Trap
- VEGF Trap-Eye
- velafermin
- velaglucerase alfa
- Velcade
- Velcera
- Velcura Therapeutics
- velneperit
- Velocigene technology
- Velos
- vemurafenib
- VenatoRx
- VenBio
- Venrock Associates
- Ventana
- VentiRx
- Ventura County
- Venture Capital
- venture capital firm
- Venture Capital fund
- venture funding
- venture money
- Venus Remedies
- Verastem
- Verdezyne
- Verenium
- Verio Therapeutics
- Verispan
- Vermillion
- Vermont
- vernakalant
- Vernalis
- VeroScience
- Versartis
- vertex
- Verus Pharmaceuticals
- VGX Pharmaceuticals
- VIA Pharmaceuticals
- VIA-2291
- ViaCyte
- Viagra
- VIAject
- Viamet Pharmaceuticals
- Vibativ
- Vical
- Vicept
- vicriviroc
- Victory Pharma
- Victoza
- Victrelis
- Vicuron Pharmaceuticals
- Vidaza
- Video Games
- vidofludimus
- Viibryd
- Viiv
- Vilazodone
- Vimpat
- Vion Pharmaceuticals
- VioQuest
- Vioxx
- vipadenant
- viprinex
- Viraferon
- Viragen
- Viral Genetics
- Virdante Pharmaceuticals
- Viread
- Virent Energy Systems
- Virginia Tech
- ViroChem
- Viromed
- Viropharma
- Virosome Biologicals
- Virtify
- Virtual model
- virus
- vismodegib
- Vitae Pharmaceuticals
- Vital Therapies
- Vitamin C
- Vitamin D
- Vivalis
- Vivus
- Vladimir Martin
- VLST
- voclosporin
- voluntary recall
- vorapaxar
- Voraxaze
- Voreloxin
- Votrient
- VPRIV
- VR315
- VRX698
- VX-222
- VX-509
- VX-765
- VX-770
- Vyteris
- Vytorin
- Wake Forest Baptist Medical Center
- Wake Forest University School Of Medicine
- Wal-Mart
- Walgreen's
- Wall Street
- Warburg Pincus
- Warfarin
- Warner Chilcott
- Warp Drive Bio
- Warren Cooper
- Warren Levy
- Warwick Medical School
- Washington
- Water Street Healthcare Partners
- Watson Pharmaceuticals
- Wave Biotech
- Weaver syndrome
- web marketing
- Welcome Trust
- Wellcome Trust
- WellGen
- Wellstat Therapeutics
- West Pharmaceutical
- Wex Pharmaceuticals
- Wilex
- Wisconsin
- Wockhardt
- Wolters Kluwer Health
- Women in Biotech
- workforce
- workforce expansion
- World Health Organization
- WorldCare Clinical
- wound care
- WuXi
- Wyeth
- Xalkori
- Xanodyne
- Xarelto
- Xcelience
- Xcellerex
- Xeloda
- Xenazine
- Xencor
- Xenome
- Xenon
- Xenoport
- Xention
- Xgeva
- Xiaflex
- Xiamen Innovax Biotech
- Xience
- Xifaxan
- Xigris
- XL139
- XL147
- XL184
- XL228
- XL281
- XL413
- XL499
- XL647
- XL765
- XL784
- XL880
- XmAb587
- XMT-1107
- Xoma
- XOMA 052
- Xomaxon
- XORI
- Xphase Pharmaceuticals
- XTL Biopharmaceuticals
- Yale School of Medicine
- Yale University
- Yasuchika Hasegawa
- Yaupo Therapeutics
- Yaupon Therapeutics
- Yervoy
- YM Biosciences
- Yondelis
- York Pharma
- Yoshihiko Hatanaka
- young scientists
- ZabeCor
- Zacharon
- Zactima
- ZafGen
- Zalbin
- Zalicus
- Zaltrap
- zalutumumab
- Zambon
- Zavesca
- Zcube
- ZD4054
- Zealand Pharma
- Zebinix
- Zelboraf
- Zeldox
- Zelnorm
- Zelrix
- Zeltia
- Zentiva
- Zenvia
- Zenyaku Kogyo
- Zerenex
- Zevalin
- zibotentan
- Zila
- Zingo
- Ziopharm Oncology
- Zocor
- Zogenix
- Zolpimist
- Zosano Pharma
- ZP1846
- Zuplenz
- Zydus Pharmaceuticals
- Zymafos
- Zymeworks
- ZymoGenetics
- Zyngenia
- Zyprexa
- Zytiga
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
